{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:30:24Z","timestamp":1793305824058,"version":"4.5.0"},"reference-count":576,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"\n Background<\/jats:title>\n Alzheimer's disease (AD) is a chronic, progressive neurodegenerative disorder characterized by cognitive decline, memory loss, and impaired reasoning. It is the leading cause of dementia in older adults, marked by the pathological accumulation of amyloid-beta plaques and neurofibrillary tangles. These pathological changes lead to widespread neuronal damage, significantly impacting daily functioning and quality of life.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This comprehensive review aims to explore various aspects of Alzheimer's disease, including its epidemiology, risk factors, clinical presentation, diagnostic advancements, management strategies, caregiving challenges, and emerging therapeutic interventions.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A systematic literature review was conducted across multiple electronic databases, including PubMed, MEDLINE, Cochrane Library, and Scopus, from their inception to May 2024. The search strategy incorporated a combination of keywords and Medical Subject Headings (MeSH) terms such as \u201cAlzheimer's disease,\u201d \u201cepidemiology,\u201d \u201crisk factors,\u201d \u201csymptoms,\u201d \u201cdiagnosis,\u201d \u201cmanagement,\u201d \u201ccaregiving,\u201d \u201ctreatment,\u201d and \u201cnovel therapies.\u201d Boolean operators (AND, OR) were used to refine the search, ensuring a comprehensive analysis of the existing literature on Alzheimer's disease.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n AD is significantly influenced by genetic predispositions, such as the apolipoprotein E (APOE) \u03b54 allele, along with modifiable environmental factors like diet, physical activity, and cognitive engagement. Diagnostic approaches have evolved with advances in neuroimaging techniques (MRI, PET), and biomarker analysis, allowing for earlier detection and intervention. The National Institute on Aging and the Alzheimer's Association have updated diagnostic criteria to include biomarker data, enhancing early diagnosis.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n The management of AD includes pharmacological treatments, such as cholinesterase inhibitors and NMDA receptor antagonists, which provide symptomatic relief but do not slow disease progression. Emerging therapies, including amyloid-beta and tau-targeting treatments, gene therapy, and immunotherapy, offer potential for disease modification. The critical role of caregivers is underscored, as they face considerable emotional, physical, and financial burdens. Support programs, communication strategies, and educational interventions are essential for improving caregiving outcomes. While significant advancements have been made in understanding and managing AD, ongoing research is necessary to identify new therapeutic targets and enhance diagnostic and treatment strategies. A holistic approach, integrating clinical, genetic, and environmental factors, is essential for addressing the multifaceted challenges of Alzheimer's disease and improving outcomes for both patients and caregivers.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fmed.2024.1474043","type":"journal-article","created":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T23:18:49Z","timestamp":1734304729000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":225,"title":["Alzheimer's disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges"],"prefix":"10.3389","volume":"11","author":[{"given":"Saeid","family":"Safiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Ghaffari Jolfayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asra","family":"Fazlollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soroush","family":"Morsali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aila","family":"Sarkesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Daei Sorkhabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnam","family":"Golabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Aletaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimia","family":"Motlagh Asghari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Hamidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Ehsan","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepehr","family":"Jamalkhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid","family":"Karamzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Shamekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Mohammadinasab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J. M.","family":"Sullman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fikrettin","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali-Asghar","family":"Kolahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1017\/S1041610203008664","article-title":"The ABC of Alzheimer's disease: cognitive changes and their management in Alzheimer's disease and related dementias","volume":"14","author":"Corey-Bloom","year":"2002","journal-title":"Int Psychogeriatr."},{"key":"B2","volume-title":"Alzheimer Disease.","author":"Kumar","year":"2022"},{"key":"B3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/978-94-007-5416-4_14","article-title":"Alzheimer's disease","volume":"65","author":"De-Paula","year":"2012","journal-title":"Subcell Biochem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.neuron.2005.01.040","article-title":"Intraneuronal A\u03b2 causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice","volume":"45","author":"Billings","year":"2005","journal-title":"Neuron."},{"key":"B5","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1017\/S135561771700100X","article-title":"Alzheimer's disease: past, present, and future","volume":"23","author":"Bondi","year":"2017","journal-title":"J Int Neuropsychol Soc."},{"key":"B6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s004060050027","article-title":"The case described by Alois Alzheimer in 1911. Historical and conceptual perspectives based on the clinical record and neurohistological sections","volume":"248","author":"M\u00f6ller","year":"1998","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/S0140-6736(19)30851-7","article-title":"Alzheimer's disease","volume":"393","author":"Barnett","year":"2019","journal-title":"Lancet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem Biophys Res Commun."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.1073\/pnas.83.11.4044","article-title":"Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease","volume":"83","author":"KoSIK","year":"1986","journal-title":"Proc Nat Acad Sci USA."},{"key":"B10","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1016\/S0021-9258(17)38495-8","article-title":"Microtubule-associated protein tau. A component of Alzheimer paired helical filaments","volume":"261","author":"Grundke-Iqbal","year":"1986","journal-title":"J Biol Chem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/00002093-199806000-00007","article-title":"Safety of Tacrine: clinical trials, treatment IND, and postmarketing experience","volume":"12","author":"Gracon","year":"1998","journal-title":"Alzheimer Dis Assoc Disord."},{"key":"B12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"B13","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology."},{"key":"B14","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack Jr","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B15","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement."},{"key":"B16","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup","volume":"20","author":"Jack CR","year":"2024","journal-title":"Alzheimers Dement."},{"key":"B17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1146\/annurev.publhealth.23.100901.140525","article-title":"The public health impact of Alzheimer's disease, 2000\u20132050: potential implication of treatment advances","volume":"23","author":"Sloane","year":"2002","journal-title":"Annu Rev Public Health."},{"key":"B18","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s40120-022-00338-8","article-title":"Alzheimer's disease: epidemiology and clinical progression","volume":"11","author":"Tahami Monfared","year":"2022","journal-title":"Neurol Therapy."},{"key":"B19","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S1474-4422(16)00127-7","article-title":"Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond","volume":"15","author":"Cuyvers","year":"2016","journal-title":"Lancet Neurol."},{"key":"B20","first-page":"65","article-title":"Causes of Alzheimer's disease","volume":"162","author":"Munoz","year":"2000","journal-title":"CMAJ."},{"key":"B21","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jalz.2016.01.012","article-title":"Molecular genetics of early-onset Alzheimer's disease revisited","volume":"12","author":"Cacace","year":"2016","journal-title":"Alzheimers Dement."},{"key":"B22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/archneurol.2011.221","article-title":"Autosomal recessive causes likely in early-onset Alzheimer disease","volume":"69","author":"Wingo","year":"2012","journal-title":"Arch Neurol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.arcmed.2012.10.017","article-title":"Genetics of Alzheimer's disease","volume":"43","author":"Alonso Vilatela","year":"2012","journal-title":"Arch Med Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/0891988710383571","article-title":"Genetics of Alzheimer disease","volume":"23","author":"Bekris LM Yu","year":"2010","journal-title":"J Geriatr Psychiatry Neurol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","article-title":"Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective","volume":"120","author":"Tanzi","year":"2005","journal-title":"Cell."},{"key":"B26","author":"Thompson","year":"1986","journal-title":"Thompson and Thompson Genetics in Medicine"},{"key":"B27","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science."},{"key":"B28","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3233\/JAD-160836","article-title":"Down syndrome, partial trisomy 21, and absence of Alzheimer's disease: the role of APP","volume":"56","author":"Doran","year":"2017","journal-title":"J Alzheimers Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/gim.2015.117","article-title":"The genetic landscape of Alzheimer disease: clinical implications and perspectives","volume":"18","author":"Van Cauwenberghe","year":"2016","journal-title":"Genet Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature11283","article-title":"A mutation in APP protects against Alzheimer's disease and age-related cognitive decline","volume":"488","author":"Jonsson","year":"2012","journal-title":"Nature."},{"key":"B31","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2147\/CIA.S105769","article-title":"Genes associated with Alzheimer's disease: an overview and current status","volume":"11","author":"Giri","year":"2016","journal-title":"Clin Interv Aging."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1002\/humu.22117","article-title":"Locus-specific mutation databases for neurodegenerative brain diseases","volume":"33","author":"Cruts","year":"2012","journal-title":"Hum Mutat."},{"key":"B33","doi-asserted-by":"publisher","first-page":"15132","DOI":"10.18632\/oncotarget.23738","article-title":"The genes associated with early-onset Alzheimer's disease","volume":"9","author":"Dai","year":"2018","journal-title":"Oncotarget."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e12155","DOI":"10.1002\/dad2.12155","article-title":"Insight into the genetic etiology of Alzheimer's disease: a comprehensive review of the role of rare variants","volume":"13","author":"Hoogmartens","year":"2021","journal-title":"Alzheimers Dement."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","article-title":"Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease","volume":"43","author":"Saunders","year":"1993","journal-title":"Neurology."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc Natl Acad Sci USA."},{"key":"B37","first-page":"1034","article-title":"Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage","volume":"48","author":"Pericak-Vance","year":"1991","journal-title":"Am J Hum Genet."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/s41591-019-0611-3","article-title":"Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report","volume":"25","author":"Arboleda-Velasquez","year":"2019","journal-title":"Nat Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.278.16.1349","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis APOE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA."},{"key":"B40","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng0694-180","article-title":"Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease","volume":"7","author":"Corder","year":"1994","journal-title":"Nat Genet."},{"key":"B41","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/1098-2272(200010)19:3<202::AID-GEPI2>3.3.CO;2-H","article-title":"Estimation of apolipoprotein E genotype-specific relative mortality risks from the distribution of genotypes in centenarians and middle-aged men: apolipoprotein E gene is a \u201cfrailty gene,\u201d not a \u201clongevity gene\u201d","volume":"19","author":"Gerdes","year":"2000","journal-title":"Genet Epidemiol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1086\/339269","article-title":"Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis","volume":"70","author":"Schmidt","year":"2002","journal-title":"Am J Hum Genet."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e1002548","DOI":"10.1371\/journal.pgen.1002548","article-title":"Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database","volume":"8","author":"Lill","year":"2012","journal-title":"PLoS Genet."},{"key":"B44","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/em.20233","article-title":"An apolipoprotein E variant may protect against age-related macular degeneration through cytokine regulation","volume":"47","author":"Bojanowski","year":"2006","journal-title":"Environ Mol Mutagen."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e3691","DOI":"10.1371\/journal.pone.0003691","article-title":"The genetics of primary haemorrhagic stroke, subarachnoid haemorrhage and ruptured intracranial aneurysms in adults","volume":"3","author":"Peck","year":"2008","journal-title":"PLoS ONE."},{"key":"B46","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ng.76","article-title":"Newly identified loci that influence lipid concentrations and risk of coronary artery disease","volume":"40","author":"Willer","year":"2008","journal-title":"Nat Genet."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e29848","DOI":"10.1371\/journal.pone.0029848","article-title":"Genetic signatures of exceptional longevity in humans","volume":"7","author":"Sebastiani","year":"2012","journal-title":"PLoS ONE."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/alzrt59","article-title":"Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease","volume":"3","author":"Bateman","year":"2011","journal-title":"Alzheimers Res Therapy."},{"key":"B49","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1001\/archneurol.2010.88","article-title":"An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease","volume":"67","author":"Roses","year":"2010","journal-title":"Arch Neurol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1086\/302553","article-title":"Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum","volume":"65","author":"Campion","year":"1999","journal-title":"Am J Hum Genet."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gm34","article-title":"Genetics of Alzheimer's disease: recent advances","volume":"1","author":"Avramopoulos","year":"2009","journal-title":"Genome Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.3390\/ijerph7103760","article-title":"Chronic cigarette smoking: implications for neurocognition and brain neurobiology","volume":"7","author":"Durazzo","year":"2010","journal-title":"Int J Environ Res Public Health."},{"key":"B53","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s11065-007-9035-9","article-title":"The effects of tobacco smoke and nicotine on cognition and the brain","volume":"17","author":"Swan","year":"2007","journal-title":"Neuropsychol Rev."},{"key":"B54","doi-asserted-by":"publisher","first-page":"S122","DOI":"10.1016\/j.jalz.2014.04.009","article-title":"Smoking and increased Alzheimer's disease risk: a review of potential mechanisms","volume":"10","author":"Durazzo","year":"2014","journal-title":"Alzheimers Dement"},{"key":"B55","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1474-4422(11)70072-2","article-title":"The projected effect of risk factor reduction on Alzheimer's disease prevalence","volume":"10","author":"Barnes","year":"2011","journal-title":"Lancet Neurol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/WAD.0b013e3182420b6e","article-title":"Smoking, death, and Alzheimer disease: a case of competing risks","volume":"26","author":"Chang","year":"2012","journal-title":"Alzheimer Dis Assoc Disord."},{"key":"B57","unstructured":"The chemical constituents in cigarettes and cigarette smoke: priorities for harm reduction\n BatesM\n NoitonD\n Priorities Harm Reduct.2000"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2011.07.002","article-title":"Inflammation in the early stages of neurodegenerative pathology","volume":"238","author":"Khandelwal","year":"2011","journal-title":"J Neuroimmunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cca.2006.08.028","article-title":"Monitoring micronutrients in cigarette smokers","volume":"377","author":"Northrop-Clewes","year":"2007","journal-title":"Clin Chim Acta."},{"key":"B60","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1179\/1351000213Y.0000000052","article-title":"Oxidative stress in Alzheimer's disease: primary villain or physiological by-product?","volume":"18","author":"Sutherland","year":"2013","journal-title":"Redox Rep."},{"key":"B61","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3727\/194982412X13378627621752","article-title":"Evaluation of how cigarette smoke is a direct risk factor for Alzheimer's disease","volume":"14","author":"Giunta","year":"2012","journal-title":"Technol Innov."},{"key":"B62","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.smrv.2017.06.010","article-title":"Sleep disturbances increase the risk of dementia: a systematic review and meta-analysis","volume":"40","author":"Shi","year":"2018","journal-title":"Sleep Med Rev."},{"key":"B63","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/ana.22468","article-title":"Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women","volume":"70","author":"Tranah","year":"2011","journal-title":"Ann Neurol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"zsz017","DOI":"10.1093\/sleep\/zsz017","article-title":"Sleep-wake regulation and the hallmarks of the pathogenesis of Alzheimer's disease","volume":"42","author":"Van Egroo","year":"2019","journal-title":"Sleep"},{"key":"B65","doi-asserted-by":"publisher","first-page":"525970","DOI":"10.3389\/fnins.2020.525970","article-title":"Local sleep and Alzheimer's disease pathophysiology","volume":"14","author":"Mander","year":"2020","journal-title":"Front Neurosci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1159\/000533700","article-title":"Association between sleep and Alzheimer's disease: a bibliometric analysis from 2003 to 2022","volume":"57","author":"Tang","year":"2023","journal-title":"Neuroepidemiology."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1001\/jamaneurol.2021.2876","article-title":"Association of short and long sleep duration with amyloid-\u03b2 burden and cognition in aging","volume":"78","author":"Winer","year":"2021","journal-title":"JAMA Neurol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41386-019-0478-5","article-title":"Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors","volume":"45","author":"Wang","year":"2020","journal-title":"Neuropsychopharmacology."},{"key":"B69","doi-asserted-by":"publisher","first-page":"aau6550","DOI":"10.1126\/scitranslmed.aau6550","article-title":"Reduced non-rapid eye movement sleep is associated with tau pathology in early Alzheimer's disease","volume":"11","author":"Lucey","year":"2019","journal-title":"Sci Transl Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S1474-4422(18)30450-2","article-title":"Implications of sleep disturbance and inflammation for Alzheimer's disease dementia","volume":"18","author":"Irwin","year":"2019","journal-title":"Lancet Neurol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"875138","DOI":"10.3389\/fncel.2022.875138","article-title":"Possible neuropathology of sleep disturbance linking to Alzheimer's disease: astrocytic and microglial roles","volume":"16","author":"Xiao","year":"2022","journal-title":"Front Cell Neurosci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"R1371","DOI":"10.1016\/j.cub.2021.08.026","article-title":"The glymphatic system","volume":"31","author":"Hablitz","year":"2021","journal-title":"Curr Biol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.1241224","article-title":"Sleep drives metabolite clearance from the adult brain","volume":"342","author":"Xie","year":"2013","journal-title":"Science."},{"key":"B74","doi-asserted-by":"publisher","first-page":"110995","DOI":"10.1016\/j.biopha.2020.110995","article-title":"Association between chronic stress and Alzheimer's disease: therapeutic effects of Saffron","volume":"133","author":"Saeedi","year":"2021","journal-title":"Biomed Pharmacother."},{"key":"B75","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0006-3223(00)00964-1","article-title":"Effects of adverse experiences for brain structure and function","volume":"48","author":"McEwen","year":"2000","journal-title":"Biol Psychiatry."},{"key":"B76","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0306-4522(95)00259-L","article-title":"Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors","volume":"69","author":"Magarin","year":"1995","journal-title":"Neuroscience."},{"key":"B77","doi-asserted-by":"publisher","first-page":"8278","DOI":"10.1523\/JNEUROSCI.2121-07.2007","article-title":"Chronic glucocorticoids increase hippocampal vulnerability to neurotoxicity under conditions that produce CA3 dendritic retraction but fail to impair spatial recognition memory","volume":"27","author":"Conrad","year":"2007","journal-title":"J Neurosci."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1523\/JNEUROSCI.17-07-02492.1997","article-title":"Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation","volume":"17","author":"Gould","year":"1997","journal-title":"J Neurosci."},{"key":"B79","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.pnpbp.2009.11.003","article-title":"A critical review of chronic stress effects on spatial learning and memory","volume":"34","author":"Conrad","year":"2010","journal-title":"Progr Neuropsychopharmacol Biol Psychiatry."},{"key":"B80","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1749-6632.2001.tb05830.x","article-title":"Plasticity of the hippocampus: adaptation to chronic stress and allostatic load","volume":"933","author":"McEwen","year":"2001","journal-title":"Ann N Y Acad Sci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.nlm.2011.02.016","article-title":"Chronic stress, cognitive functioning and mental health","volume":"96","author":"Marin","year":"2011","journal-title":"Neurobiol Learn Mem."},{"key":"B82","doi-asserted-by":"publisher","first-page":"7840","DOI":"10.1523\/JNEUROSCI.0730-11.2011","article-title":"Stress acts cumulatively to precipitate Alzheimer's disease-like tau pathology and cognitive deficits","volume":"31","author":"Sotiropoulos","year":"2011","journal-title":"J Neurosci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"9047","DOI":"10.1523\/JNEUROSCI.2797-06.2006","article-title":"Glucocorticoids increase amyloid-\u03b2 and tau pathology in a mouse model of Alzheimer's disease","volume":"26","author":"Green","year":"2006","journal-title":"J Neurosci."},{"key":"B84","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jamda.2008.02.007","article-title":"Physical activity and Alzheimer's disease: from prevention to therapeutic perspectives","volume":"9","author":"Rolland","year":"2008","journal-title":"J Am Med Dir Assoc."},{"key":"B85","doi-asserted-by":"publisher","first-page":"876","DOI":"10.4065\/mcp.2011.0252","article-title":"Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging","volume":"86","author":"Ahlskog","year":"2011","journal-title":"Mayo Clin Proc."},{"key":"B86","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1001\/jamaneurol.2017.0244","article-title":"Evaluation of amyloid protective factors and Alzheimer disease neurodegeneration protective factors in elderly individuals","volume":"74","author":"Vemuri","year":"2017","journal-title":"JAMA Neurol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"Dementia prevention, intervention, and care","volume":"390","author":"Livingston","year":"2017","journal-title":"Lancet."},{"key":"B88","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1017\/S0033291708003681","article-title":"Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence","volume":"39","author":"Hamer","year":"2009","journal-title":"Psychol Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1136\/bjsports-2015-095699","article-title":"Aerobic exercise ameliorates cognitive function in older adults with mild cognitive impairment: a systematic review and meta-analysis of randomised controlled trials","volume":"50","author":"Zheng","year":"2016","journal-title":"Br J Sports Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.apmr.2004.03.019","article-title":"The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis","volume":"85","author":"Heyn","year":"2004","journal-title":"Arch Phys Med Rehabil."},{"key":"B91","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1159\/000223730","article-title":"Exercise and mental health: many reasons to move","volume":"59","author":"Deslandes","year":"2009","journal-title":"Neuropsychobiology."},{"key":"B92","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.neubiorev.2005.10.004","article-title":"Exercise, cognition and Alzheimer's disease: more is not necessarily better","volume":"30","author":"Eggermont","year":"2006","journal-title":"Neurosci Biobehav Rev."},{"key":"B93","doi-asserted-by":"publisher","first-page":"13427","DOI":"10.1073\/pnas.96.23.13427","article-title":"Running enhances neurogenesis, learning, and long-term potentiation in mice","volume":"96","author":"Van Praag","year":"1999","journal-title":"Proc Nat Acad Sci USA."},{"key":"B94","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neuroscience.2003.09.029","article-title":"Effects of voluntary exercise on synaptic plasticity and gene expression in the dentate gyrus of adult male Sprague\u2013Dawley rats in vivo","volume":"124","author":"Farmer","year":"2004","journal-title":"Neuroscience."},{"key":"B95","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1073\/pnas.1015950108","article-title":"Exercise training increases size of hippocampus and improves memory","volume":"108","author":"Erickson","year":"2011","journal-title":"Proc Nat Acad Sci USA."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1002\/jmri.24085","article-title":"Masters athletes exhibit larger regional brain volume and better cognitive performance than sedentary older adults","volume":"38","author":"Tseng","year":"2013","journal-title":"J Magn Reson Imaging."},{"key":"B97","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/ggi.12784","article-title":"Effect of elastic band-based high-speed power training on cognitive function, physical performance and muscle strength in older women with mild cognitive impairment","volume":"17","author":"Yoon","year":"2017","journal-title":"Geriatr Gerontol Int."},{"key":"B98","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/ana.22096","article-title":"Exercise and Alzheimer's disease biomarkers in cognitively normal older adults","volume":"68","author":"Liang","year":"2010","journal-title":"Ann Neurol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/archneurol.2009.307","article-title":"Effects of aerobic exercise on mild cognitive impairment: a controlled trial","volume":"67","author":"Baker","year":"2010","journal-title":"Arch Neurol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.1523\/JNEUROSCI.0496-05.2005","article-title":"Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease","volume":"25","author":"Adlard","year":"2005","journal-title":"J Neurosci."},{"key":"B101","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/bpa.12255","article-title":"Voluntary running attenuates memory loss, decreases neuropathological changes and induces neurogenesis in a mouse model of a Lzheimer's disease","volume":"26","author":"Tapia-Rojas","year":"2016","journal-title":"Brain Pathol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-9-54","article-title":"Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice","volume":"9","author":"Ohia-Nwoko","year":"2014","journal-title":"Mol Neurodegener."},{"key":"B103","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.nbd.2011.04.022","article-title":"Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology","volume":"43","author":"Belarbi","year":"2011","journal-title":"Neurobiol Dis."},{"key":"B104","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jshs.2020.01.004","article-title":"Physical exercise in the prevention and treatment of Alzheimer's disease","volume":"9","author":"De la Rosa","year":"2020","journal-title":"J Sport Health Sci"},{"key":"B105","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3389\/fnagi.2019.00146","article-title":"Modifiable risk factors for Alzheimer's disease","volume":"11","author":"Edwards GA","year":"2019","journal-title":"Front Aging Neurosci."},{"key":"B106","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1001\/jamainternmed.2013.359","article-title":"Effects of the Finnish Alzheimer disease exercise trial (FINALEX): a randomized controlled trial","volume":"173","author":"Pitk\u00e4l\u00e4","year":"2013","journal-title":"JAMA Intern Med."},{"key":"B107","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1532-5415.2007.01035.x","article-title":"Exercise program for nursing home residents with Alzheimer's disease: a 1-year randomized, controlled trial","volume":"55","author":"Rolland","year":"2007","journal-title":"J Am Geriatr Soc."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.cct.2012.08.002","article-title":"A community-based approach to trials of aerobic exercise in aging and Alzheimer's disease","volume":"33","author":"Vidoni","year":"2012","journal-title":"Contemp Clin Trials."},{"key":"B109","doi-asserted-by":"publisher","first-page":"e0170547","DOI":"10.1371\/journal.pone.0170547","article-title":"Aerobic exercise for Alzheimer's disease: a randomized controlled pilot trial","volume":"12","author":"Morris","year":"2017","journal-title":"PLoS ONE."},{"key":"B110","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.jalz.2015.05.016","article-title":"Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective","volume":"11","author":"Baumgart","year":"2015","journal-title":"Alzheimers Dement."},{"key":"B111","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2147\/NDT.S198772","article-title":"Alcohol and dementia - what is the link? A systematic review","volume":"16","author":"Wiegmann","year":"2020","journal-title":"Neuropsychiatr Dis Treat."},{"key":"B112","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1186\/1471-2458-14-643","article-title":"Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis","volume":"14","author":"Beydoun","year":"2014","journal-title":"BMC Public Health."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/gps.2470","article-title":"Association between alcohol consumption and cognitive impairment in Southern Chinese older adults","volume":"25","author":"Chan","year":"2010","journal-title":"Int J Geriatr Psychiatry."},{"key":"B114","doi-asserted-by":"publisher","first-page":"e2254771","DOI":"10.1001\/jamanetworkopen.2022.54771","article-title":"Changes in alcohol consumption and risk of dementia in a nationwide cohort in South Korea","volume":"6","author":"Jeon","year":"2023","journal-title":"JAMA Netw Open"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.2174\/1567205013666160603005035","article-title":"The association between alcohol use and the progression of Alzheimer's disease","volume":"13","author":"Heymann","year":"2016","journal-title":"Curr Alzheimer Res."},{"key":"B116","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.biopha.2003.12.004","article-title":"Alcohol and tobacco consumption as risk factors of dementia: a review of epidemiological studies","volume":"58","author":"Letenneur","year":"2004","journal-title":"Biomed Pharmacother."},{"key":"B117","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1007\/s00018-018-2872-2","article-title":"Inhibition of protein misfolding and aggregation by natural phenolic compounds","volume":"75","author":"Dhouafli","year":"2018","journal-title":"Cell Mol Life Sci."},{"key":"B118","doi-asserted-by":"publisher","first-page":"9492","DOI":"10.3390\/ijms24119492","article-title":"Alcohol as a modifiable risk factor for Alzheimer's disease\u2014evidence from experimental studies","volume":"24","author":"Chandrashekar","year":"2023","journal-title":"Int J Mol Sci."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-018-0453-0","article-title":"Alcohol use and dementia: a systematic scoping review","volume":"11","author":"Rehm","year":"2019","journal-title":"Alzheimers Res Ther."},{"key":"B120","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1016\/S2468-2667(18)30022-7","article-title":"Contribution of alcohol use disorders to the burden of dementia in France 2008-13: a nationwide retrospective cohort study","volume":"3","author":"Schwarzinger","year":"2018","journal-title":"Lancet Public Health."},{"key":"B121","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s00213-002-1281-1","article-title":"Acute alcohol effects on cognitive function in social drinkers: their relationship to drinking habits","volume":"165","author":"Weissenborn","year":"2003","journal-title":"Psychopharmacology."},{"key":"B122","doi-asserted-by":"publisher","first-page":"j2353","DOI":"10.1136\/bmj.j2353","article-title":"Moderate alcohol consumption as risk factor for adverse brain outcomes and cognitive decline: longitudinal cohort study","volume":"357","author":"Topiwala","year":"2017","journal-title":"BMJ."},{"key":"B123","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neuroscience.2017.08.013","article-title":"Adolescent binge ethanol exposure alters specific forebrain cholinergic cell populations and leads to selective functional deficits in the prefrontal cortex","volume":"361","author":"Fernandez","year":"2017","journal-title":"Neuroscience."},{"key":"B124","doi-asserted-by":"publisher","first-page":"e0204500","DOI":"10.1371\/journal.pone.0204500","article-title":"Adolescent binge ethanol-induced loss of basal forebrain cholinergic neurons and neuroimmune activation are prevented by exercise and indomethacin","volume":"13","author":"Vetreno","year":"2018","journal-title":"PLoS ONE."},{"key":"B125","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1038\/s41598-018-20424-y","article-title":"Beneficial effects of low alcohol exposure, but adverse effects of high alcohol intake on glymphatic function","volume":"8","author":"Lundgaard","year":"2018","journal-title":"Sci Rep."},{"key":"B126","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/psyg.12008","article-title":"Changes in Mini-Mental State Examination score in Alzheimer's disease patients after stopping habitual drinking","volume":"13","author":"Toda","year":"2013","journal-title":"Psychogeriatrics."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1001\/archneur.62.10.1556","article-title":"Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease","volume":"62","author":"Kivipelto","year":"2005","journal-title":"Arch Neurol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2174\/156720507780362263","article-title":"Relation of obesity to cognitive function: importance of central obesity and synergistic influence of concomitant hypertension. The Framingham Heart Study","volume":"4","author":"Wolf","year":"2007","journal-title":"Curr Alzheimer Res."},{"key":"B129","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1001\/archneurol.2008.582","article-title":"Midlife and late-life obesity and the risk of dementia: cardiovascular health study","volume":"66","author":"Fitzpatrick","year":"2009","journal-title":"Arch Neurol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1212\/WNL.0b013e3181c0d4b6","article-title":"Adiposity indicators and dementia over 32 years in Sweden","volume":"73","author":"Gustafson","year":"2009","journal-title":"Neurology."},{"key":"B131","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3233\/JAD-130698","article-title":"Midlife and late-life body mass index and late-life dementia: results from a prospective population-based cohort","volume":"38","author":"Tolppanen","year":"2014","journal-title":"J Alzheimers Dis."},{"key":"B132","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jalz.2017.06.2637","article-title":"Obesity trajectories and risk of dementia: 28 years of follow-up in the Whitehall II Study","volume":"14","author":"Singh-Manoux","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B133","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.jalz.2017.09.016","article-title":"Body mass index and risk of dementia: Analysis of individual-level data from 13 million individuals","volume":"14","author":"Kivim\u00e4ki","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B134","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3233\/JAD181028","article-title":"Is Alzheimer's disease risk modifiable?","volume":"67","author":"Serrano-Pozo","year":"2019","journal-title":"J Alzheimers Dis."},{"key":"B135","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.3390\/nu11092181","article-title":"The interplay of diet quality and Alzheimer's disease genetic risk score in relation to cognitive performance among Urban African Americans","volume":"11","author":"Hossain","year":"2019","journal-title":"Nutrients"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1533317520907168","DOI":"10.1177\/1533317520907168","article-title":"Nutritional and functional indicators and their association with mortality among older adults with Alzheimer's disease","volume":"35","author":"de Sousa","year":"2020","journal-title":"Am J Alzheimers Dis Other Dement."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1147177","DOI":"10.3389\/fnins.2023.1147177","article-title":"Effect of nutrition in Alzheimer's disease: a systematic review","volume":"17","author":"Xu Lou","year":"2023","journal-title":"Front Neurosci"},{"key":"B138","doi-asserted-by":"publisher","first-page":"741534","DOI":"10.3389\/fnut.2021.741534","article-title":"High glycemic diet is related to brain amyloid accumulation over one year in preclinical Alzheimer's disease","volume":"8","author":"Taylor","year":"2021","journal-title":"Front Nutr."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/alz.12114","article-title":"Refined carbohydrate-rich diet is associated with long-term risk of dementia and Alzheimer's disease in apolipoprotein E \u03b54 allele carriers","volume":"16","author":"Gentreau","year":"2020","journal-title":"Alzheimers Dement."},{"key":"B140","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/alz.12421","article-title":"Mediterranean and Western diet effects on Alzheimer's disease biomarkers, cerebral perfusion, and cognition in mid-life: a randomized trial","volume":"18","author":"Hoscheidt","year":"2022","journal-title":"Alzheimers Dement."},{"key":"B141","doi-asserted-by":"publisher","first-page":"700","DOI":"10.3390\/nu13020700","article-title":"Mediterranean diet and risk of dementia and Alzheimer's disease in the EPIC-Spain dementia cohort study","volume":"13","author":"Andreu-Rein\u00f3n","year":"2021","journal-title":"Nutrients."},{"key":"B142","doi-asserted-by":"publisher","first-page":"e2920","DOI":"10.1212\/WNL.0000000000012067","article-title":"Melo van Lent D, Brunner J, Schr\u00f6der A, Wolfsgruber S, Altenstein S, et al. Mediterranean diet, Alzheimer disease biomarkers, and brain atrophy in old age","volume":"96","author":"Ballarini","year":"2021","journal-title":"Neurology."},{"key":"B143","doi-asserted-by":"publisher","first-page":"50","DOI":"10.14283\/jpad.2018.44","article-title":"Diet as a risk factor for cognitive decline in African Americans and Caucasians with a parental history of Alzheimer's disease: a cross-sectional pilot study dietary patterns","volume":"6","author":"Nutaitis","year":"2019","journal-title":"J Prev Alzheimers Dis."},{"key":"B144","doi-asserted-by":"publisher","first-page":"e0182048","DOI":"10.1371\/journal.pone.0182048","article-title":"Mediterranean diet and cognitive health: Initial results from the Hellenic Longitudinal Investigation of Ageing and Diet","volume":"12","author":"Anastasiou","year":"2017","journal-title":"PLoS ONE."},{"key":"B145","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/ana.20854","article-title":"Mediterranean diet and risk for Alzheimer's disease","volume":"59","author":"Scarmeas","year":"2006","journal-title":"Ann Neurol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.numecd.2014.09.006","article-title":"Exploring the path of Mediterranean diet on 10-year incidence of cardiovascular disease: the ATTICA study (2002\u20132012)","volume":"25","author":"Panagiotakos","year":"2015","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"B147","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/ana.22317","article-title":"Mediterranean diet and magnetic resonance imaging\u2013assessed cerebrovascular disease","volume":"69","author":"Scarmeas","year":"2011","journal-title":"Ann Neurol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1001\/archneur.63.12.noc60109","article-title":"Mediterranean diet, Alzheimer disease, and vascular mediation","volume":"63","author":"Scarmeas","year":"2006","journal-title":"Arch Neurol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"e1789","DOI":"10.1212\/WNL.0000000000005527","article-title":"Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adults","volume":"90","author":"Berti","year":"2018","journal-title":"Neurology."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1002\/alz.12154","article-title":"Dietary fatty acids and risk of Alzheimer's disease and related dementias: observations from the Washington Heights-Hamilton Heights-Inwood Columbia Aging Project (WHICAP)","volume":"16","author":"Gustafson","year":"2020","journal-title":"Alzheimers Dement."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.3390\/nu14061159","article-title":"Higher serum DHA and slower cognitive decline in patients with Alzheimer's disease: two-year follow-up","volume":"14","author":"Chu","year":"2022","journal-title":"Nutrients."},{"key":"B152","doi-asserted-by":"publisher","first-page":"5397","DOI":"10.1111\/ejn.15373","article-title":"Potential neurobiological links between social isolation and Alzheimer's disease risk","volume":"56","author":"Drinkwater","year":"2022","journal-title":"Eur J Neurosci."},{"key":"B153","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1126\/science.3399889","article-title":"Social relationships and health","volume":"241","author":"House","year":"1988","journal-title":"Science."},{"key":"B154","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/geronb\/gbz152","article-title":"Social isolation and memory decline in later-life","volume":"75","author":"Read","year":"2020","journal-title":"J Gerontol B Psychol Sci Soc Sci."},{"key":"B155","doi-asserted-by":"publisher","first-page":"1075563","DOI":"10.3389\/fnagi.2023.1075563","article-title":"Are social isolation and loneliness associated with cognitive decline in ageing?","volume":"15","author":"Cardona","year":"2023","journal-title":"Front Aging Neurosci."},{"key":"B156","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/002214650905000103","article-title":"Social disconnectedness, perceived isolation, and health among older adults","volume":"50","author":"Cornwell","year":"2009","journal-title":"J Health Soc Behav."},{"key":"B157","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S1474-4422(12)70191-6","article-title":"Cognitive reserve in ageing and Alzheimer's disease","volume":"11","author":"Stern","year":"2012","journal-title":"Lancet Neurol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1212\/WNL.57.12.2236","article-title":"Influence of leisure activity on the incidence of Alzheimer's disease","volume":"57","author":"Scarmeas","year":"2001","journal-title":"Neurology."},{"key":"B159","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1001\/jama.1994.03510370056032","article-title":"Influence of education and occupation on the incidence of Alzheimer's disease","volume":"271","author":"Stern","year":"1994","journal-title":"JAMA."},{"key":"B160","doi-asserted-by":"publisher","first-page":"e0201008","DOI":"10.1371\/journal.pone.0201008","article-title":"Social isolation, cognitive reserve, and cognition in healthy older people","volume":"13","author":"Evans","year":"2018","journal-title":"PLoS ONE."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1212\/WNL.0b013e31828ab370","article-title":"Predicting cognitive decline","volume":"80","author":"Kaffashian","year":"2013","journal-title":"Neurology."},{"key":"B162","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1212\/WNL.0b013e318236ef23","article-title":"Vascular risk factors and cognitive impairment in a stroke-free cohort","volume":"77","author":"Unverzagt","year":"2011","journal-title":"Neurology."},{"key":"B163","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.3233\/JAD-141812","article-title":"Adverse vascular risk is related to cognitive decline in older adults","volume":"44","author":"Jefferson","year":"2015","journal-title":"J Alzheimers Dis."},{"key":"B164","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1016\/j.neurobiolaging.2015.07.023","article-title":"Framingham risk score can predict cognitive decline progression in Alzheimer's disease","volume":"36","author":"Viticchi","year":"2015","journal-title":"Neurobiol Aging."},{"key":"B165","doi-asserted-by":"publisher","first-page":"l4414","DOI":"10.1136\/bmj.l4414","article-title":"Association of ideal cardiovascular health at age 50 with incidence of dementia: 25 year follow-up of Whitehall II cohort study","volume":"366","author":"Sabia","year":"2019","journal-title":"BMJ."},{"key":"B166","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/j.1532-5415.2005.53360.x","article-title":"Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the cardiovascular health study cohort","volume":"53","author":"Newman","year":"2005","journal-title":"J Am Geriatr Soc."},{"key":"B167","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3233\/JAD-215153","article-title":"Diabetes mellitus, elevated Hemoglobin A 1c, and glycated albumin are associated with the presence of all-cause dementia and Alzheimer's disease: the JPSC-AD Study","volume":"85","author":"Noguchi-Shinohara","year":"2022","journal-title":"J Alzheimers Dis."},{"key":"B168","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jalz.2018.06.3060","article-title":"Prediabetes and diabetes accelerate cognitive decline and predict microvascular lesions: a population-based cohort study","volume":"15","author":"Marseglia","year":"2019","journal-title":"Alzheimers Dement."},{"key":"B169","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/S1474-4422(14)70136-X","article-title":"Potential for primary prevention of Alzheimer's disease: an analysis of population-based data","volume":"13","author":"Norton","year":"2014","journal-title":"Lancet Neurol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.2337\/dc18-0073","article-title":"Long-term glycemic control and dementia risk in type 1 diabetes","volume":"41","author":"Lacy","year":"2018","journal-title":"Diabetes Care."},{"key":"B171","doi-asserted-by":"publisher","first-page":"e2316182","DOI":"10.1001\/jamanetworkopen.2023.16182","article-title":"Patterns of regional brain atrophy and brain aging in middle- and older-aged adults with type 1 diabetes","volume":"6","author":"Habes","year":"2023","journal-title":"JAMA Netw Open"},{"key":"B172","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1176\/appi.neuropsych.20230043","article-title":"Depression as a risk factor for dementia: a meta-analysis","volume":"36","author":"Fern\u00e1ndez Fern\u00e1ndez","year":"2024","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"B173","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1192\/bjp.bp.112.118307","article-title":"Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies","volume":"202","author":"Diniz","year":"2018","journal-title":"Br J Psychiatry."},{"key":"B174","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1001\/archpsyc.63.5.530","article-title":"Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis","volume":"63","author":"Ownby","year":"2006","journal-title":"Arch Gen Psychiatry."},{"key":"B175","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1212\/WNL.40.10.1513","article-title":"An estimate of the incidence of dementia in idiopathic Parkinson's disease","volume":"40","author":"Mayeux","year":"1990","journal-title":"Neurology"},{"key":"B176","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1136\/jnnp.55.7.566","article-title":"A controlled, longitudinal study of dementia in Parkinson's disease","volume":"55","author":"Biggins","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B177","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1001\/archneur.1995.00540310069018","article-title":"The frequency and associated risk factors for dementia in patients with Parkinson's disease","volume":"52","author":"Marder","year":"1995","journal-title":"Arch Neurol."},{"key":"B178","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1136\/jnnp.64.2.178","article-title":"Neuropsychological prediction of dementia in Parkinson's disease","volume":"64","author":"Mahieux","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B179","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1212\/WNL.54.8.1596","article-title":"A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease","volume":"54","author":"Hughes","year":"2000","journal-title":"Neurology."},{"key":"B180","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1212\/WNL.56.6.730","article-title":"Kragh\u2013S\u00f8rensen P. Risk of dementia in Parkinson's disease","volume":"56","author":"Aarsland","year":"2001","journal-title":"Neurology."},{"key":"B181","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/mds.20216","article-title":"Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom","volume":"19","author":"Hobson","year":"2004","journal-title":"Mov Disord."},{"key":"B182","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/brain\/awm111","article-title":"Evolution of cognitive dysfunction in an incident Parkinson's disease cohort","volume":"130","author":"Williams-Gray","year":"2007","journal-title":"Brain."},{"key":"B183","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1093\/brain\/awp245","article-title":"The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort","volume":"132","author":"Williams-Gray","year":"2009","journal-title":"Brain."},{"key":"B184","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jalz.2011.09.230","article-title":"Risk of dementia in an elderly population of Parkinson's disease patients: a 15-year population-based study","volume":"8","author":"Perez","year":"2012","journal-title":"Alzheimers Dement."},{"key":"B185","doi-asserted-by":"publisher","first-page":"16759","DOI":"10.1038\/s41598-022-21093-8","article-title":"High risk of developing dementia in Parkinson's disease: a Swedish registry-based study","volume":"12","author":"\u00c5str\u00f6m","year":"2022","journal-title":"Sci Rep."},{"key":"B186","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1136\/jnnp.2006.108076","article-title":"Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's disease","volume":"78","author":"Bronnick","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B187","doi-asserted-by":"publisher","first-page":"815063","DOI":"10.3389\/fendo.2022.815063","article-title":"The Association between thyroid diseases and alzheimer's disease in a National Health Screening Cohort in Korea","volume":"13","author":"Kim","year":"2022","journal-title":"Front Endocrinol"},{"key":"B188","doi-asserted-by":"publisher","first-page":"276","DOI":"10.14283\/jpad.2023.20","article-title":"The role of thyroid dysfunction in Alzheimer's disease: a systematic review and meta-analysis","volume":"10","author":"Salehipour","year":"2023","journal-title":"J Prev Alzheimers Dis."},{"key":"B189","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1093\/ije\/20.Supplement_2.S36","article-title":"Medical history and the risk of Alzheimer's disease: a collaborative re-analysis of case-control studies","volume":"20","author":"Breteler","year":"1991","journal-title":"Int J Epidemiol"},{"key":"B190","doi-asserted-by":"publisher","first-page":"e679","DOI":"10.1212\/WNL.0000000000200740","article-title":"Thyroid disorders and dementia risk","volume":"99","author":"Wieland","year":"2022","journal-title":"Neurology."},{"key":"B191","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/cen.14424","article-title":"Increased risk of dementia in hypothyroidism: a Danish nationwide register-based study","volume":"94","author":"Thvilum","year":"2021","journal-title":"Clin Endocrinol."},{"key":"B192","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1001\/archinte.168.14.1514","article-title":"Thyroid function and the risk of Alzheimer disease: The Framingham Study","volume":"168","author":"Tan","year":"2008","journal-title":"Arch Intern Med."},{"key":"B193","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1001\/jamaneurol.2013.5402","article-title":"Hypothyroidism and risk of mild cognitive impairment in elderly persons: a population-based study","volume":"71","author":"Parsaik","year":"2014","journal-title":"JAMA Neurol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"1137584","DOI":"10.3389\/fnagi.2023.1137584","article-title":"Association of thyroid disease with risks of dementia and cognitive impairment: a meta-analysis and systematic review","volume":"15","author":"Ma","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"B195","doi-asserted-by":"publisher","first-page":"6726","DOI":"10.3390\/jcm11226726","article-title":"Association of hypothyroidism and the risk of cognitive dysfunction: a meta-analysis","volume":"11","author":"Ye","year":"2022","journal-title":"J Clin Med."},{"key":"B196","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1111\/j.1532-5415.2004.52508.x","article-title":"Cognitive impairment in chronic kidney disease","volume":"52","author":"Kurella","year":"2004","journal-title":"J Am Geriatr Soc."},{"key":"B197","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s00415-018-9016-3","article-title":"Magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment","volume":"266","author":"Chandra","year":"2019","journal-title":"J Neurol."},{"key":"B198","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1212\/WNL.0b013e31823b4765","article-title":"Chronic kidney disease, cognitive decline, and incident dementia","volume":"77","author":"Helmer","year":"2011","journal-title":"Neurology."},{"key":"B199","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.3390\/biomedicines11061606","article-title":"Exploring the link between chronic kidney disease and Alzheimer's disease: a longitudinal follow-up study using the Korean National Health Screening Cohort","volume":"11","author":"Kwon","year":"2023","journal-title":"Biomedicines."},{"key":"B200","doi-asserted-by":"publisher","first-page":"e2956","DOI":"10.1212\/WNL.0000000000012113","article-title":"Kidney function, kidney function decline, and the risk of dementia in older adults","volume":"96","author":"Xu","year":"2021","journal-title":"Neurology."},{"key":"B201","doi-asserted-by":"publisher","first-page":"e2252387","DOI":"10.1001\/jamanetworkopen.2022.52387","article-title":"Association of kidney function with development of Alzheimer disease and other dementias and dementia-related blood biomarkers","volume":"6","author":"Stocker","year":"2023","journal-title":"JAMA Netw Open"},{"key":"B202","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1097\/NEN.0b013e31818fc72f","article-title":"Preservation of neuronal number despite age-related cortical brain atrophy in elderly subjects without Alzheimer disease","volume":"67","author":"Freeman","year":"2008","journal-title":"J Neuropathol Exp Neurol."},{"key":"B203","first-page":"531","article-title":"Rate of change of common measures of impairment in senile dementia of the Alzheimer type","volume":"24","author":"JA","year":"1988","journal-title":"Psychopharmacol Bull."},{"key":"B204","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S1474-4422(03)00262-X","article-title":"Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment","volume":"2","author":"DeCarli","year":"2003","journal-title":"Lancet Neurol."},{"key":"B205","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.jalz.2014.06.004","article-title":"Innovative diagnostic tools for early detection of Alzheimer's disease","volume":"11","author":"Laske","year":"2015","journal-title":"Alzheimers Dement."},{"key":"B206","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer's disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol Neurodegener."},{"key":"B207","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1055\/s-2006-956757","article-title":"Vascular dementia: emerging trends","volume":"27","author":"Aggarwal","year":"2007","journal-title":"Semin Neurol."},{"key":"B208","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1017\/S1355617708080302","article-title":"Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease","volume":"14","author":"Grober","year":"2008","journal-title":"J Int Neuropsychol Soc."},{"key":"B209","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1212\/WNL.46.3.661","article-title":"Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study","volume":"46","author":"Tierney","year":"1996","journal-title":"Neurology."},{"key":"B210","doi-asserted-by":"publisher","first-page":"a006148","DOI":"10.1101\/cshperspect.a006148","article-title":"The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment","volume":"2","author":"Tarawneh","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B211","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2190\/X09P-N7AU-UCHA-VW08","article-title":"Language impairment in dementia of the Alzheimer type: a hierarchical decline?","volume":"30","author":"Emery","year":"2000","journal-title":"Int J Psychiatry Med."},{"key":"B212","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0093-934X(82)90006-2","article-title":"A study of language functioning in Alzheimer patients","volume":"17","author":"Appell","year":"1982","journal-title":"Brain Lang."},{"key":"B213","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/0093-934X(92)90132-X","article-title":"Dysnomia in Alzheimer's disease: an evaluation of neurobehavioral subtypes","volume":"43","author":"Goldstein","year":"1992","journal-title":"Brain Lang."},{"key":"B214","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/WCO.0000000000001182","article-title":"Atypical forms of Alzheimer's disease: patients not to forget","volume":"36","author":"Montembeault","year":"2023","journal-title":"Curr Opin Neurol."},{"key":"B215","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1600-0404.1999.tb07339.x","article-title":"Dyscalculia in the early stages of Alzheimer's disease","volume":"99","author":"Carlomagno","year":"1999","journal-title":"Acta Neurol Scand."},{"key":"B216","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.neuropsychologia.2007.01.006","article-title":"Decision-making with explicit and stable rules in mild Alzheimer's disease","volume":"45","author":"Delazer","year":"2007","journal-title":"Neuropsychologia."},{"key":"B217","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1080\/01688639008401013","article-title":"Recovery of orientation following closed-head injury","volume":"12","author":"High Jr","year":"1990","journal-title":"J Clin Exp Neuropsychol."},{"key":"B218","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/00005053-196408000-00003","article-title":"Temporal orientation in cerebral disease","volume":"139","author":"Benton","year":"1964","journal-title":"J Nerv Ment Dis."},{"key":"B219","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1212\/WNL.61.11.1491","article-title":"Spatial disorientation in Alzheimer's disease: the remembrance of things passed","volume":"61","author":"Monacelli","year":"2003","journal-title":"Neurology."},{"key":"B220","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.pscychresns.2008.11.002","article-title":"The neural basis of visuospatial perception in Alzheimer's disease and healthy elderly comparison subjects: an fMRI study","volume":"172","author":"Thiyagesh","year":"2009","journal-title":"Psychiatry Res."},{"key":"B221","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S1474-4422(11)70289-7","article-title":"Posterior cortical atrophy","volume":"11","author":"Crutch","year":"2012","journal-title":"Lancet Neurol."},{"key":"B222","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s004060050101","article-title":"Clinical features of Alzheimer's disease","volume":"249","author":"F\u00f6rstl","year":"1999","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"B223","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/gps.2631","article-title":"Depression in Alzheimer's disease: specificity of depressive symptoms using three different clinical criteria","volume":"26","author":"Engedal","year":"2011","journal-title":"Int J Geriatr Psychiatry."},{"key":"B224","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1519\/JPT.0000000000000020","article-title":"Balance and gait of adults with very mild Alzheimer's disease","volume":"38","author":"Gras","year":"2001","journal-title":"J Geriatr Phys Ther."},{"key":"B225","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1212\/WNL.34.8.1114","article-title":"Extrapyramidal signs in Alzheimer's disease","volume":"34","author":"M\u00f6ls\u00e4","year":"1984","journal-title":"Neurology"},{"key":"B226","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1017\/S1041610297005036","article-title":"Neurologic markers of the progression of Alzheimer's disease","volume":"9","author":"Franssen","year":"1997","journal-title":"Int Psychogeriatr."},{"key":"B227","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1037\/t13385-000","article-title":"Behavioral symptoms in Alzheimer's disease: phenomenology and treatment","volume":"48","author":"Reisberg","year":"1987","journal-title":"J Clin Psychiatry."},{"key":"B228","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1017\/S1041610297003529","article-title":"Behavioral pathology in Alzheimer's disease (BEHAVE-AD) rating scale","volume":"8","author":"Reisberg","year":"1997","journal-title":"Int Psychogeriatr."},{"key":"B229","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1017\/S1041610211000974","article-title":"Frontotemporal atrophy associated with paranoid delusions in women with Alzheimer's disease","volume":"24","author":"Whitehead","year":"2012","journal-title":"Int Psychogeriatr."},{"key":"B230","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1001\/archneur.1987.00520210031015","article-title":"The Neurologic examination in patients with probable Alzheimer's disease","volume":"44","author":"Huff","year":"1987","journal-title":"Arch Neurol."},{"key":"B231","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J Neuropathol Exp Neurol."},{"key":"B232","doi-asserted-by":"publisher","first-page":"445","DOI":"10.31887\/DCNS.2013.15.4\/hjahn","article-title":"Memory loss in Alzheimer's disease","volume":"15","author":"Jahn","year":"2013","journal-title":"Dialog Clin Neurosci."},{"key":"B233","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jalz.2016.06.2365","article-title":"Detecting cognitive changes in preclinical Alzheimer's disease: a review of its feasibility","volume":"13","author":"Mortamais","year":"2017","journal-title":"Alzheimers Dement."},{"key":"B234","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2217\/nmt.12.5","article-title":"Appraisal of cognition in preclinical Alzheimer's disease: a conceptual review","volume":"2","author":"Knopman","year":"2012","journal-title":"Neurodegener Dis Manag."},{"key":"B235","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev.psych.57.102904.190024","article-title":"Neuropsychological assessment of dementia","volume":"60","author":"Salmon","year":"2009","journal-title":"Annu Rev Psychol."},{"key":"B236","doi-asserted-by":"publisher","first-page":"13547","DOI":"10.1073\/pnas.93.24.13547","article-title":"Cognitive and neurobiologic markers of early Alzheimer disease","volume":"93","author":"Albert","year":"1996","journal-title":"Proc Nat Acad Sci USA."},{"key":"B237","doi-asserted-by":"publisher","first-page":"P98","DOI":"10.1093\/geronb\/60.2.P98","article-title":"Personality change precedes clinical diagnosis of dementia of the Alzheimer type","volume":"60","author":"Balsis","year":"2005","journal-title":"J Gerontol B Psychol Sci Soc Sci."},{"key":"B238","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jpsychires.2016.12.024","article-title":"Relations between personality changes and cerebrospinal fluid biomarkers of Alzheimer's disease pathology","volume":"90","author":"Tautvydaite","year":"2017","journal-title":"J Psychiatr Res."},{"key":"B239","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/gps.2655","article-title":"Personality changes in Alzheimer's disease: a systematic review","volume":"26","author":"Robins Wahlin","year":"2011","journal-title":"Int J Geriatr Psychiatry."},{"key":"B240","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1177\/070674371105600704","article-title":"personality changes in patients with beginning Alzheimer disease","volume":"56","author":"Pocnet","year":"2011","journal-title":"Can J Psychiatry."},{"key":"B241","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1080\/13607860601086603","article-title":"Personality changes in Alzheimer's disease","volume":"11","author":"Talassi","year":"2007","journal-title":"Aging Ment Health."},{"key":"B242","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3233\/JAD-190601","article-title":"Balance and mobility performance along the Alzheimer's disease spectrum","volume":"73","author":"Yoon","year":"2020","journal-title":"J Alzheimers Dis."},{"key":"B243","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3233\/JAD-2009-0987","article-title":"An abnormal \u201cone-leg balance\u201d test predicts cognitive decline during Alzheimer's disease","volume":"16","author":"Rolland","year":"2009","journal-title":"J Alzheimers Dis."},{"key":"B244","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/PHM.0b013e31823caeea","article-title":"Balance and mobility dysfunction and falls risk in older people with mild to moderate Alzheimer disease","volume":"91","author":"Suttanon","year":"2012","journal-title":"Am J Phys Med Rehabil."},{"key":"B245","doi-asserted-by":"publisher","first-page":"110816","DOI":"10.1016\/j.exger.2019.110816","article-title":"Gait analysis with videogrammetry can differentiate healthy elderly, mild cognitive impairment, and Alzheimer's disease: a cross-sectional study","volume":"131","author":"de Oliveira Silva","year":"2020","journal-title":"Exp Gerontol."},{"key":"B246","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.gaitpost.2017.01.024","article-title":"What can gait tell us about dementia? Review of epidemiological and neuropsychological evidence","volume":"53","author":"Valkanova","year":"2017","journal-title":"Gait Post."},{"key":"B247","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.gaitpost.2013.12.026","article-title":"A longitudinal study of gait function and characteristics of gait disturbance in individuals with Alzheimer's disease","volume":"39","author":"Cedervall","year":"2014","journal-title":"Gait Post."},{"key":"B248","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1176\/appi.ajp.158.8.1319","article-title":"Sensory gating deficit expressed by a disturbed suppression of the P50 event-related potential in patients with Alzheimer's disease","volume":"158","author":"Jessen","year":"2001","journal-title":"Am J Psychiatry."},{"key":"B249","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1055\/s-2004-818389","article-title":"The impact of Alzheimer's disease on the pain processing","volume":"7","author":"Kunz","year":"2004","journal-title":"Fortschr Neurol Psychiatr."},{"key":"B250","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/ageing\/26.6.497","article-title":"The experience and expression of pain in Alzheimer patients","volume":"26","author":"Fisher-Morris","year":"1997","journal-title":"Age Ageing."},{"key":"B251","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.3233\/JAD-150436","article-title":"Palmomental reflex a relevant sign in early Alzheimer's disease diagnosis?","volume":"49","author":"Gabelle","year":"2016","journal-title":"J Alzheimers Dis."},{"key":"B252","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/089198879500800207","article-title":"Primitive reflexes in Alzheimer's disease and vascular dementia","volume":"8","author":"Vreeling","year":"1995","journal-title":"J Geriatr Psychiatry Neurol."},{"key":"B253","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-141173","article-title":"Eye movements in Alzheimer's disease","volume":"44","author":"Molitor","year":"2015","journal-title":"J Alzheimers Dis."},{"key":"B254","doi-asserted-by":"publisher","first-page":"5349","DOI":"10.3390\/s20185349","article-title":"Analyzing facial and eye movements to screen for Alzheimer's disease","volume":"20","author":"Nam","year":"2020","journal-title":"Sensors"},{"key":"B255","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00401-016-1613-6","article-title":"Ocular indicators of Alzheimer's: exploring disease in the retina","volume":"132","author":"Hart","year":"2016","journal-title":"Acta Neuropathol."},{"key":"B256","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/opo.12220","article-title":"Oculo-visual changes and clinical considerations affecting older patients with dementia","volume":"35","author":"Armstrong","year":"2015","journal-title":"Ophthal Physiol Optics."},{"key":"B257","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jalz.2013.06.004","article-title":"Alzheimer's disease in the human eye. Clinical tests that identify ocular and visual information processing deficit as biomarkers","volume":"10","author":"Chang","year":"2014","journal-title":"Alzheimers Dement."},{"key":"B258","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fneur.2016.00055","article-title":"Visual and ocular manifestations of Alzheimer's disease and their use as biomarkers for diagnosis and progression","volume":"7","author":"Javaid","year":"2016","journal-title":"Front Neurol"},{"key":"B259","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3233\/JAD-140507","article-title":"Macular pigment, visual function, and macular disease among subjects with Alzheimer's disease: an exploratory study","volume":"42","author":"Nolan","year":"2014","journal-title":"J Alzheimers Dis."},{"key":"B260","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.survophthal.2013.10.002","article-title":"Vision function abnormalities in Alzheimer disease","volume":"59","author":"Tzekov","year":"2014","journal-title":"Surv Ophthalmol."},{"key":"B261","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.dadm.2016.12.014","article-title":"Retinal thickness in Alzheimer's disease: a systematic review and meta-analysis","volume":"6","author":"den Haan","year":"2017","journal-title":"Alzheimers Dement."},{"key":"B262","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/BF02251474","article-title":"Extrapyramidal signs in Alzheimer's disease: a 3-year follow-up study","volume":"4","author":"Soininen","year":"1992","journal-title":"J Neural Transm Park Dis Dement Sect."},{"key":"B263","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/archneur.1997.00550200033007","article-title":"Extrapyramidal signs in patients with probable Alzheimer disease","volume":"54","author":"Lopez","year":"1997","journal-title":"Arch Neurol."},{"key":"B264","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1001\/archneur.1991.00530230049020","article-title":"Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease","volume":"48","author":"Chen","year":"1991","journal-title":"Arch Neurol."},{"key":"B265","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/00002093-199601020-00008","article-title":"Extrapyramidal motor signs in clinically diagnosed Alzheimer disease","volume":"10","author":"Ellis","year":"1996","journal-title":"Alzheimer Dis Assoc Disord."},{"key":"B266","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1212\/01.WNL.0000138440.39918.0C","article-title":"Motor signs during the course of Alzheimer disease","volume":"63","author":"Scarmeas","year":"2004","journal-title":"Neurology."},{"key":"B267","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1212\/WNL.54.6.1284","article-title":"Progression of parkinsonian signs in Alzheimer's disease","volume":"54","author":"Wilson","year":"2000","journal-title":"Neurology."},{"key":"B268","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/1533317508328602","article-title":"Reviews: current concepts in Alzheimer's disease: a multidisciplinary review","volume":"24","author":"Minati","year":"2009","journal-title":"Am J Alzheimers Dis Other Dement."},{"key":"B269","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/ageing\/afu053","article-title":"How does additional diagnostic testing influence the initial diagnosis in patients with cognitive complaints in a memory clinic setting?","volume":"44","author":"Meijs","year":"2015","journal-title":"Age Ageing."},{"key":"B270","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement."},{"key":"B271","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fnagi.2013.00055","article-title":"Biomarker-based prediction of progression in MCI: comparison of AD-signature and hippocampal volume with spinal fluid amyloid-\u03b2 and tau","volume":"5","author":"Dickerson","year":"2013","journal-title":"Front Aging Neurosci"},{"key":"B272","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1212\/WNL.0000000000001399","article-title":"Subjective cognitive decline is related to CSF biomarkers of AD in patients with MCI","volume":"84","author":"Steffen","year":"2015","journal-title":"Neurology."},{"key":"B273","doi-asserted-by":"publisher","first-page":"S289","DOI":"10.3233\/JAD-179904","article-title":"A blood test for Alzheimer's disease: progress, challenges, and recommendations","volume":"64","author":"Kiddle","year":"2018","journal-title":"J Alzheimers Dis."},{"key":"B274","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-\u03b2 biomarkers for Alzheimer's disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature."},{"key":"B275","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jalz.2017.06.2266","article-title":"Amyloid \u03b2 concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis","volume":"13","author":"Ovod","year":"2017","journal-title":"Alzheimers Dement."},{"key":"B276","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","article-title":"Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia","volume":"26","author":"Janelidze","year":"2020","journal-title":"Nat Med."},{"key":"B277","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41591-020-0762-2","article-title":"Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration","volume":"26","author":"Thijssen","year":"2020","journal-title":"Nat Med."},{"key":"B278","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrn3961","article-title":"Compromised autophagy and neurodegenerative diseases","volume":"16","author":"Menzies","year":"2015","journal-title":"Nat Rev Neurosci."},{"key":"B279","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","article-title":"meta-analysis of cytokines in Alzheimer's disease","volume":"68","author":"Swardfager","year":"2010","journal-title":"Biol Psychiatry."},{"key":"B280","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2147\/JIR.S86958","article-title":"Targeting neuroinflammation in Alzheimer's disease","volume":"9","author":"Bronzuoli","year":"2016","journal-title":"J Inflamm Res."},{"key":"B281","doi-asserted-by":"publisher","first-page":"e867","DOI":"10.1212\/WNL.0000000000006082","article-title":"CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease","volume":"91","author":"Janelidze","year":"2018","journal-title":"Neurology."},{"key":"B282","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12974-017-0893-7","article-title":"YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer's disease and other tauopathies","volume":"14","author":"Querol-Vilaseca","year":"2017","journal-title":"J Neuroinflamm."},{"key":"B283","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13195-022-01051-2","article-title":"Inflammatory plasma biomarkers in subjects with preclinical Alzheimer's disease","volume":"14","author":"Prins","year":"2022","journal-title":"Alzheimers Res Ther."},{"key":"B284","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/359325a0","article-title":"Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids","volume":"359","author":"Seubert","year":"1992","journal-title":"Nature."},{"key":"B285","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol."},{"key":"B286","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1212\/01.WNL.0000046581.81650.D0","article-title":"Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study","volume":"60","author":"Strozyk","year":"2003","journal-title":"Neurology."},{"key":"B287","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1001\/archneur.56.6.673","article-title":"Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease","volume":"56","author":"Andreasen","year":"1999","journal-title":"Arch Neurol."},{"key":"B288","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1021\/pr0703627","article-title":"Characterization of amyloid beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry","volume":"6","author":"Portelius","year":"2007","journal-title":"J Proteome Res."},{"key":"B289","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1021\/pr050475v","article-title":"Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry","volume":"5","author":"Portelius","year":"2006","journal-title":"J Proteome Res."},{"key":"B290","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000100926","article-title":"Prediction of Alzheimer's disease using the CSF Abeta42\/Abeta40 ratio in patients with mild cognitive impairment","volume":"23","author":"Hansson","year":"2007","journal-title":"Dement Geriatr Cogn Disord."},{"key":"B291","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0197-4580(03)00086-1","article-title":"Neurochemical diagnosis of Alzheimer's dementia by CSF Abeta42, Abeta42\/Abeta40 ratio and total tau","volume":"25","author":"Lewczuk","year":"2004","journal-title":"Neurobiol Aging."},{"key":"B292","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/j.1471-4159.2006.04404.x","article-title":"Amyloid beta peptide ratio 42\/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load","volume":"101","author":"Wiltfang","year":"2007","journal-title":"J Neurochem."},{"key":"B293","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13195-015-0114-5","article-title":"Cerebrospinal fluid amyloid-\u03b2 42\/40 ratio in clinical setting of memory centers: a multicentric study","volume":"7","author":"Dumurgier","year":"2015","journal-title":"Alzheimers Res Ther."},{"key":"B294","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3233\/JAD-2011-110161","article-title":"Tau transgenic mice as models for cerebrospinal fluid tau biomarkers","volume":"2","author":"Barten","year":"2011","journal-title":"J Alzheimers Dis."},{"key":"B295","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fnins.2016.00031","article-title":"Tau: the center of a signaling nexus in Alzheimer's disease","volume":"10","author":"Khan","year":"2016","journal-title":"Front Neurosci."},{"key":"B296","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.exger.2009.10.010","article-title":"Total and phosphorylated tau protein as biological markers of Alzheimer's disease","volume":"45","author":"Hampel","year":"2010","journal-title":"Exp Gerontol."},{"key":"B297","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","article-title":"CSF markers for incipient Alzheimer's disease","volume":"2","author":"Blennow","year":"2003","journal-title":"Lancet Neurol."},{"key":"B298","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1001\/archneur.63.9.1277","article-title":"Neurochemical aftermath of amateur boxing","volume":"63","author":"Zetterberg","year":"2006","journal-title":"Arch Neurol."},{"key":"B299","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0304-3940(00)01697-9","article-title":"Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke","volume":"297","author":"Hesse","year":"2001","journal-title":"Neurosci Lett."},{"key":"B300","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/ana.20477","article-title":"Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease","volume":"57","author":"Grossman","year":"2005","journal-title":"Ann Neurol."},{"key":"B301","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1212\/01.wnl.0000311445.21321.fc","article-title":"CSF biomarkers in frontotemporal lobar degeneration with known pathology","volume":"70","author":"Bian","year":"2008","journal-title":"Neurology."},{"key":"B302","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0304-3940(00)01036-3","article-title":"Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization","volume":"285","author":"Vanmechelen","year":"2000","journal-title":"Neurosci Lett."},{"key":"B303","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1159\/000077170","article-title":"Total and phosphorylated tau proteins: evaluation as core biomarker candidates in frontotemporal dementia","volume":"17","author":"Hampel","year":"2004","journal-title":"Dement Geriatr Cogn Disord."},{"key":"B304","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1001\/archpsyc.61.1.95","article-title":"Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study","volume":"61","author":"Hampel","year":"2004","journal-title":"Arch Gen Psychiatry."},{"key":"B305","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1176\/appi.ajp.160.2.376","article-title":"Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231","volume":"160","author":"Buerger","year":"2003","journal-title":"Am J Psychiatry."},{"key":"B306","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41591-020-0781-z","article-title":"A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease","volume":"26","author":"Barth\u00e9lemy NR Li","year":"2020","journal-title":"Nat Med."},{"key":"B307","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1212\/WNL.59.4.627","article-title":"CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects","volume":"59","author":"Buerger","year":"2002","journal-title":"Neurology."},{"key":"B308","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1093\/brain\/awl269","article-title":"CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease","volume":"129","author":"Buerger","year":"2006","journal-title":"Brain"},{"key":"B309","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1159\/000216841","article-title":"Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4\/epsilon4 genotype","volume":"27","author":"Blom","year":"2009","journal-title":"Dement Geriatr Cogn Disord."},{"key":"B310","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1212\/01.wnl.0000183284.92920.f2","article-title":"Phosphorylated tau predicts rate of cognitive decline in MCI subjects: a comparative CSF study","volume":"65","author":"Buerger","year":"2005","journal-title":"Neurology."},{"key":"B311","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/gps.2353","article-title":"Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity","volume":"25","author":"S\u00e4mg\u00e5rd","year":"2010","journal-title":"Int J Geriatr Psychiatry."},{"key":"B312","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/ana.111.abs","article-title":"Tracking of Alzheimer's disease progression with cerebrospinal fluid tau protein phosphorylated at threonine 231","volume":"49","author":"Hampel","year":"2001","journal-title":"Ann Neurol."},{"key":"B313","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1001\/archneur.62.5.770","article-title":"Correlation of cerebrospinal fluid levels of tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease","volume":"62","author":"Hampel","year":"2005","journal-title":"Arch Neurol."},{"key":"B314","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1212\/01.wnl.0000286944.22262.ff","article-title":"Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI","volume":"69","author":"Ewers","year":"2007","journal-title":"Neurology."},{"key":"B315","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.104729","article-title":"Neurofilaments at a glance","author":"Yuan","year":"2012"},{"key":"B316","doi-asserted-by":"publisher","first-page":"a018309","DOI":"10.1101\/cshperspect.a018309","article-title":"Neurofilaments and neurofilament proteins in health and disease","volume":"9","author":"Yuan","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B317","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0306-4522(94)90310-7","article-title":"Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease","volume":"62","author":"Vickers","year":"1994","journal-title":"Neuroscience."},{"key":"B318","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1136\/jnnp.64.3.402","article-title":"Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis","volume":"64","author":"Lycke","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B319","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000101843","article-title":"A systematic review and meta-analysis of CSF neurofilament protein levels as biomarkers in dementia","volume":"4","author":"Petzold","year":"2007","journal-title":"Neurodegener Dis."},{"key":"B320","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/jnr.1242","article-title":"Neurofilament protein in cerebrospinal fluid: a marker of white matter changes","volume":"66","author":"Sj\u00f6gren","year":"2001","journal-title":"J Neurosci Res."},{"key":"B321","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1212\/WNL.0000000000004088","article-title":"CSF sAPP\u03b2, YKL-40, and neurofilament light in frontotemporal lobar degeneration","volume":"89","author":"Alcolea","year":"2017","journal-title":"Neurology."},{"key":"B322","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.neuint.2017.05.010","article-title":"Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease","volume":"108","author":"Lista","year":"2017","journal-title":"Neurochem Int."},{"key":"B323","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1001\/jamaneurol.2015.3037","article-title":"Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression","volume":"73","author":"Zetterberg","year":"2016","journal-title":"JAMA Neurol."},{"key":"B324","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.neurobiolaging.2017.06.002","article-title":"Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer's disease","volume":"58","author":"Pereira","year":"2017","journal-title":"Neurobiol Aging."},{"key":"B325","doi-asserted-by":"publisher","first-page":"e271","DOI":"10.1212\/NXI.0000000000000271","article-title":"Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS","volume":"3","author":"Bergman","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B326","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ana.24980","article-title":"Phosphorylated neurofilament heavy chain: a biomarker of survival for C9ORF72-associated amyotrophic lateral sclerosis","volume":"82","author":"Gendron","year":"2017","journal-title":"Ann Neurol."},{"key":"B327","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1016\/j.jalz.2013.12.012","article-title":"Evaluation of neuroprotective effect of glucagon-like peptide 1 analogs using neuroimaging","volume":"10","author":"Femminella","year":"2014","journal-title":"Alzheimers Dement."},{"key":"B328","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","article-title":"Biomarker modeling of Alzheimer's disease","volume":"80","author":"Jack CR","year":"2013","journal-title":"Neuron."},{"key":"B329","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3109\/1354750X.2014.904001","article-title":"The potential of microRNAs as biofluid markers of neurodegenerative diseases\u2013a systematic review","volume":"19","author":"Danborg","year":"2014","journal-title":"Biomarkers."},{"key":"B330","first-page":"365","article-title":"microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF)","volume":"3","author":"Alexandrov","year":"2012","journal-title":"Int J Biochem Mol Biol."},{"key":"B331","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1039\/C6SC05615F","article-title":"Ultra-sensitive detection of protein biomarkers for diagnosis of Alzheimer's disease","volume":"8","author":"Chan","year":"2017","journal-title":"Chem Sci."},{"key":"B332","doi-asserted-by":"publisher","first-page":"13184","DOI":"10.1038\/s41598-019-49711-y","article-title":"novel kit for early diagnosis of Alzheimer's disease using a fluorescent nanoparticle imaging","volume":"9","author":"Park","year":"2019","journal-title":"Sci Rep."},{"key":"B333","doi-asserted-by":"publisher","first-page":"12050","DOI":"10.1038\/s41598-018-30487-6","article-title":"IL-1\u03b2, IL-6, TNF- \u03b1 and CRP in elderly patients with depression or Alzheimer's disease: systematic review and meta-analysis","volume":"8","author":"Ng","year":"2018","journal-title":"Sci Rep."},{"key":"B334","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2147\/DNND.S228939","article-title":"Alzheimer's disease - why we need early diagnosis","volume":"9","author":"Rasmussen","year":"2019","journal-title":"Degener Neurol Neuromuscul Dis."},{"key":"B335","doi-asserted-by":"publisher","first-page":"371","DOI":"10.14283\/jpad.2021.23","article-title":"Diagnosis of early Alzheimer's disease: clinical practice in 2021","volume":"8","author":"Porsteinsson","year":"2021","journal-title":"J Prev Alzheimers Dis."},{"key":"B336","doi-asserted-by":"publisher","first-page":"a006213","DOI":"10.1101\/cshperspect.a006213","article-title":"Brain imaging in Alzheimer disease","volume":"2","author":"Johnson","year":"2012","journal-title":"Cold Spring Harb Perspect Med."},{"key":"B337","doi-asserted-by":"publisher","first-page":"617599","DOI":"10.3389\/fpsyg.2021.617599","article-title":"A systematic review of MRI neuroimaging for education research","volume":"12","author":"Wu","year":"2021","journal-title":"Front Psychol."},{"key":"B338","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/14651858.CD009628.pub2","article-title":"Structural mri for the early diagnosis of Alzheimer disease in patients with MCI","volume":"103","author":"Butler","year":"2021","journal-title":"Am Fam Phys."},{"key":"B339","doi-asserted-by":"publisher","first-page":"191","DOI":"10.31887\/DCNS.2009.11.2\/pscheltens","article-title":"Imaging in Alzheimer's disease","volume":"11","author":"Scheltens","year":"2009","journal-title":"Dialogues Clin Neurosci."},{"key":"B340","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0197-4580(94)90032-9","article-title":"Morphological criteria for the recognition of Alzheimer's disease and the distribution pattern of cortical changes related to this disorder","volume":"15","author":"Braak","year":"1994","journal-title":"Neurobiol Aging"},{"key":"B341","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S1474-4422(02)00002-9","article-title":"Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion","volume":"1","author":"Scheltens","year":"2002","journal-title":"Lancet Neurol."},{"key":"B342","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S1474-4422(20)30314-8","article-title":"Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias","volume":"19","author":"Ch\u00e9telat","year":"2020","journal-title":"Lancet Neurol."},{"key":"B343","doi-asserted-by":"publisher","first-page":"e99010010","DOI":"10.14440\/jbm.2024.412","article-title":"Diagnosis of Alzheimer's disease: Towards accuracy and accessibility","volume":"11","author":"Mu","year":"2024","journal-title":"J Biol Methods."},{"key":"B344","doi-asserted-by":"publisher","first-page":"e053600","DOI":"10.1002\/alz.053600","article-title":"Neuropathological hallmarks of Alzheimer's disease in centenarians, in the context of aging","volume":"17","author":"Zhang","year":"2021","journal-title":"Alzheimers Dement."},{"key":"B345","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13195-018-0402-y","article-title":"In vivo quantification of neurofibrillary tangles with [18F]MK-6240","volume":"10","author":"Pascoal","year":"2018","journal-title":"Alzheimers Res Ther."},{"key":"B346","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2967\/jnmt.118.224022","article-title":"An introduction to newer PET diagnostic agents and related therapeutic radiopharmaceuticals","volume":"47","author":"Mantel","year":"2019","journal-title":"J Nucl Med Technol."},{"key":"B347","doi-asserted-by":"publisher","first-page":"838034","DOI":"10.3389\/fnagi.2022.838034","article-title":"Amyloid and tau positron emission tomography imaging in Alzheimer's disease and other tauopathies","volume":"14","author":"Maschio","year":"2022","journal-title":"Front Aging Neurosci."},{"key":"B348","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","article-title":"Tau PET imaging in neurodegenerative tauopathies-still a challenge","volume":"24","author":"Leuzy","year":"2019","journal-title":"Mol Psychiatry."},{"key":"B349","doi-asserted-by":"publisher","first-page":"829","DOI":"10.2967\/jnumed.123.266463","article-title":"Evaluation of neurodegenerative disorders with amyloid-\u03b2, tau, and dopaminergic PET imaging: interpretation pitfalls","volume":"65","author":"Burkett","year":"2024","journal-title":"J Nucl Med."},{"key":"B350","doi-asserted-by":"publisher","first-page":"612","DOI":"10.2967\/jnumed.120.257824","article-title":"Relationship between tau and cognition in the evolution of Alzheimer's disease: new insights from tau PET","volume":"62","author":"Tanner","year":"2021","journal-title":"J Nucl Med."},{"key":"B351","doi-asserted-by":"publisher","first-page":"e413","DOI":"10.1097\/RLU.0000000000000547","article-title":"Brain PET in the diagnosis of Alzheimer's disease","volume":"39","author":"Marcus","year":"2014","journal-title":"Clin Nucl Med."},{"key":"B352","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00259-008-1039-z","article-title":"FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease","volume":"36","author":"Mosconi","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B353","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3389\/fnagi.2018.00425","article-title":"18F-FDG-PET detects drastic changes in brain metabolism in the Tg4\u201342 model of Alzheimer's disease","volume":"10","author":"Bouter","year":"2019","journal-title":"Front Aging Neurosci."},{"key":"B354","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1212\/WNL.0b013e31823b9c5e","article-title":"Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD","volume":"77","author":"Rabinovici","year":"2011","journal-title":"Neurology."},{"key":"B355","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-019-0512-1","article-title":"FDG-PET as an independent biomarker for Alzheimer's biological diagnosis: a longitudinal study","volume":"11","author":"Ou","year":"2019","journal-title":"Alzheimers Res Therapy."},{"key":"B356","doi-asserted-by":"publisher","first-page":"669","DOI":"10.7326\/M19-3888","article-title":"Accuracy of biomarker testing for neuropathologically defined Alzheimer disease in older adults with dementia: a systematic review","volume":"172","author":"Fink","year":"2020","journal-title":"Ann Intern Med."},{"key":"B357","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.etap.2004.12.048","article-title":"Pharmacology and toxicology of cholinesterase inhibitors: uses and misuses of a common mechanism of action","volume":"19","author":"Pope","year":"2005","journal-title":"Environ Toxicol Pharmacol."},{"key":"B358","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1600-0404.1993.tb04245.x","article-title":"Mechanism of action of cholinesterase inhibitors in Alzheimer's disease","volume":"88","author":"H\u00e5kansson","year":"1993","journal-title":"Acta Neurol Scand."},{"key":"B359","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1080\/14740338.2022.2027905","article-title":"Compared of efficacy and safety of high-dose donepezil vs standard-dose donepezil among elderly patients with Alzheimer's disease: a systematic review and meta-analysis","volume":"21","author":"Wang","year":"2022","journal-title":"Expert Opin Drug Saf."},{"key":"B360","doi-asserted-by":"publisher","first-page":"107134","DOI":"10.1016\/j.clineuro.2022.107134","article-title":"Efficacy and safety of donepezil for mild cognitive impairment: a systematic review and meta-analysis","volume":"213","author":"Zhang","year":"2022","journal-title":"Clin Neurol Neurosurg."},{"key":"B361","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3233\/JAD-220263","article-title":"Personalized prediction of Alzheimer's disease and its treatment effects by donepezil: an individual participant data meta-analysis of eight randomized controlled trials","volume":"89","author":"Yoshida","year":"2022","journal-title":"J Alzheimers Dis."},{"key":"B362","doi-asserted-by":"publisher","first-page":"Cd001191","DOI":"10.1002\/14651858.CD001191.pub4","article-title":"Rivastigmine for Alzheimer's disease","volume":"9","author":"Birks","year":"2015","journal-title":"Cochrane Database Syst Rev."},{"key":"B363","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1474-4422(15)00389-0","article-title":"Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"15","author":"Henderson","year":"2016","journal-title":"Lancet Neurol."},{"key":"B364","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001191.pub3","article-title":"Rivastigmine for Alzheimer's disease","author":"Birks","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"B365","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1527-3458.2002.tb00221.x","article-title":"Galantamine\u2013a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease","volume":"8","author":"Lilienfeld","year":"2002","journal-title":"CNS Drug Rev."},{"key":"B366","first-page":"429","article-title":"Galantamine: a novel cholinergic agent for Alzheimer's disease","volume":"17","author":"Olazar\u00e1n","year":"2002","journal-title":"Neurologia."},{"key":"B367","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1742-1241.2003.tb10467.x","article-title":"Galantamine: a review of its use in Alzheimer's disease and vascular dementia","volume":"57","author":"Corey-Bloom","year":"2003","journal-title":"Int J Clin Pract."},{"key":"B368","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s00702-014-1358-0","article-title":"Efficacy and safety of galantamine treatment for patients with Alzheimer's disease: a meta-analysis of randomized controlled trials","volume":"122","author":"Jiang","year":"2015","journal-title":"J Neural Transm."},{"key":"B369","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1177\/106002809402800612","article-title":"Tacrine: first drug approved for Alzheimer's disease","volume":"28","author":"Crismon","year":"1994","journal-title":"Ann Pharmacother."},{"key":"B370","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pnpbp.2017.01.003","article-title":"The pharmacology of tacrine at N-methyl-d-aspartate receptors","volume":"75","author":"Horak","year":"2017","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"B371","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1001\/jama.280.20.1777","article-title":"Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration","volume":"280","author":"Qizilbash","year":"1998","journal-title":"JAMA."},{"key":"B372","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1001\/jama.271.13.992","article-title":"Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease","volume":"271","author":"Watkins","year":"1994","journal-title":"JAMA."},{"key":"B373","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41419-022-04687-y","article-title":"Amyloid \u03b2 \/ PKC-dependent alterations in NMDA receptor composition are detected in early stages of Alzheimer's disease","volume":"13","author":"Ortiz-Sanz","year":"2022","journal-title":"Cell Death Dis."},{"key":"B374","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/alz.12398","article-title":"Pathogenesis of sporadic Alzheimer's disease by deficiency of NMDA receptor subunit GluN3A","volume":"18","author":"Zhong","year":"2022","journal-title":"Alzheimers Dement."},{"key":"B375","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s10072-016-2546-5","article-title":"Dysfunction of NMDA receptors in Alzheimer's disease","volume":"37","author":"Zhang","year":"2016","journal-title":"Neurol Sci."},{"key":"B376","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.3233\/JAD-2004-6S610","article-title":"Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders","volume":"6","author":"Lipton","year":"2004","journal-title":"J Alzheimers Dis."},{"key":"B377","doi-asserted-by":"publisher","first-page":"746","DOI":"10.2174\/156720512801322564","article-title":"N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease","volume":"9","author":"Olivares","year":"2012","journal-title":"Curr Alzheimer Res."},{"key":"B378","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/ene.12707","article-title":"EFNS-ENS\/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease","volume":"22","author":"Schmidt","year":"2015","journal-title":"Eur J Neurol."},{"key":"B379","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s12640-013-9398-z","article-title":"Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer's disease","volume":"24","author":"Parsons","year":"2013","journal-title":"Neurotox Res."},{"key":"B380","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1080\/14656566.2018.1442440","article-title":"Memantine in Japanese patients with moderate to severe Alzheimer's disease: meta-analysis of multiple-index responder analyses","volume":"19","author":"Okuizumi","year":"2018","journal-title":"Expert Opin Pharmacother."},{"key":"B381","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jad.2022.03.047","article-title":"The efficacy and tolerability of memantine for depressive symptoms in major mental diseases: a systematic review and updated meta-analysis of double-blind randomized controlled trials","volume":"306","author":"Hsu","year":"2022","journal-title":"J Affect Disord."},{"key":"B382","doi-asserted-by":"publisher","first-page":"Cd003154","DOI":"10.1002\/14651858.CD003154.pub6","article-title":"Memantine for dementia","volume":"3","author":"McShane","year":"2019","journal-title":"Cochr Database Syst Rev."},{"key":"B383","doi-asserted-by":"publisher","first-page":"e0183586","DOI":"10.1371\/journal.pone.0183586","article-title":"Treatment effects between monotherapy of donepezil versus combination with memantine for Alzheimer disease: a meta-analysis","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS ONE."},{"key":"B384","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13195-018-0457-9","article-title":"Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer's disease: a network meta-analysis of 41 randomized controlled trials","volume":"10","author":"Dou","year":"2018","journal-title":"Alzheimers Res Ther."},{"key":"B385","doi-asserted-by":"publisher","first-page":"e184080","DOI":"10.1001\/jamanetworkopen.2018.4080","article-title":"Association of concomitant use of cholinesterase inhibitors or memantine with cognitive decline in Alzheimer clinical trials: a meta-analysis","volume":"1","author":"Kennedy","year":"2018","journal-title":"JAMA Netw Open."},{"key":"B386","unstructured":"AdministrationFaD\n NAMENDA2018"},{"key":"B387","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2147\/nedt.2007.3.2.245","article-title":"Memantine: efficacy and safety in mild-to-severe Alzheimer's disease","volume":"3","author":"Tampi","year":"2007","journal-title":"Neuropsychiatr Dis Treat."},{"key":"B388","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4103\/IJPC.IJPC_189_18","article-title":"Efficacy of memantine hydrochloride in neuropathic pain","volume":"25","author":"Nair","year":"2019","journal-title":"Indian J Palliat Care."},{"key":"B389","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.pnpbp.2008.01.008","article-title":"A systematic review of off-label uses of memantine for psychiatric disorders","volume":"32","author":"Zdanys","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"B390","doi-asserted-by":"publisher","first-page":"19f13163","DOI":"10.4088\/JCP.19f13163","article-title":"Augmentation with memantine in obsessive-compulsive disorder","volume":"80","author":"Andrade","year":"2019","journal-title":"J Clin Psychiatry"},{"key":"B391","doi-asserted-by":"publisher","first-page":"e2841","DOI":"10.1002\/hup.2841","article-title":"Evaluation of memantine's efficacy and safety in the treatment of children with autism spectrum disorder: a systematic review and meta-analysis","volume":"37","author":"Elnaiem","year":"2022","journal-title":"Hum Psychopharmacol."},{"key":"B392","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s40263-020-00789-3","article-title":"Application of real-world data and the REWARD framework to detect unknown benefits of memantine and identify potential disease targets for new NMDA receptor antagonists","volume":"35","author":"Kern","year":"2021","journal-title":"CNS Drugs."},{"key":"B393","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jagp.2013.11.007","article-title":"Memantine for Lewy body disorders: systematic review and meta-analysis","volume":"23","author":"Matsunaga","year":"2015","journal-title":"Am J Geriatr Psychiatry."},{"key":"B394","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/978-3-540-74806-9_15","article-title":"Ketamine","volume":"182","author":"Sinner","year":"2008","journal-title":"Handb Exp Pharmacol"},{"key":"B395","doi-asserted-by":"publisher","first-page":"104762","DOI":"10.1016\/j.neubiorev.2022.104762","volume":"139","author":"Wang","year":"2022","journal-title":"Neurosci Biobehav Rev."},{"key":"B396","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.pharmthera.2016.04.010","article-title":"Pharmacology of dextromethorphan: relevance to dextromethorphan\/quinidine (Nuedexta\u00ae) clinical use","volume":"164","author":"Taylor","year":"2016","journal-title":"Pharmacol Ther."},{"key":"B397","doi-asserted-by":"publisher","first-page":"391","DOI":"10.4103\/1673-5374.153686","article-title":"A new look at auranofin, dextromethorphan and rosiglitazone for reduction of glia-mediated inflammation in neurodegenerative diseases","volume":"10","author":"Madeira","year":"2015","journal-title":"Neural Regen Res."},{"key":"B398","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1124\/jpet.102.043166","article-title":"Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation","volume":"305","author":"Liu","year":"2003","journal-title":"J Pharmacol Exp Ther."},{"key":"B399","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s40265-014-0328-z","article-title":"Dextromethorphan\/quinidine: a review of its use in adults with pseudobulbar affect","volume":"75","author":"Yang","year":"2015","journal-title":"Drugs."},{"key":"B400","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.2147\/NDT.S30713","article-title":"Evaluating the safety and efficacy of dextromethorphan\/quinidine in the treatment of pseudobulbar affect","volume":"10","author":"Schoedel","year":"2014","journal-title":"Neuropsychiatr Dis Treat."},{"key":"B401","doi-asserted-by":"publisher","first-page":"264","DOI":"10.4140\/TCP.n.2014.264","article-title":"Dextromethorphan\/quinidine for the treatment of pseudobulbar affect","volume":"29","author":"Patatanian","year":"2014","journal-title":"Consult Pharm."},{"key":"B402","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s40263-022-00968-4","article-title":"Dextromethorphan\/bupropion: first approval","volume":"36","author":"Keam","year":"2022","journal-title":"CNS Drugs."},{"key":"B403","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s40501-020-00233-9","article-title":"pharmacological management of neuropsychiatric symptoms of dementia","volume":"7","author":"Gerlach","year":"2020","journal-title":"Curr Treat Options Psychiatry."},{"key":"B404","doi-asserted-by":"publisher","first-page":"Cd003944","DOI":"10.1002\/14651858.CD003944.pub2","article-title":"Antidepressants for treating depression in dementia","volume":"8","author":"Dudas","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"key":"B405","unstructured":"Management of neuropsychiatric symptoms of dementia\n PostTW\n Waltham, MAUpToDate IncUpToDate2023"},{"key":"B406","doi-asserted-by":"publisher","first-page":"254","DOI":"10.4140\/TCP.n.2014.254","article-title":"Antidepressants for depression in patients with dementia: a review of the literature","volume":"29","author":"Leong","year":"2014","journal-title":"Consult Pharm."},{"key":"B407","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9781615371624","article-title":"Schatzberg CBN","author":"Alan","year":""},{"key":"B408","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/gps.4709","article-title":"Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E","volume":"33","author":"Burke","year":"2018","journal-title":"Int J Geriatr Psychiatry."},{"key":"B409","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3390\/ph14090930","article-title":"Antidepressants in Alzheimer's disease: a focus on the role of mirtazapine","volume":"14","author":"Correia","year":"2021","journal-title":"Pharmaceuticals"},{"key":"B410","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3233\/JAD-161247","article-title":"Efficacy of antidepressants for depression in Alzheimer's disease: systematic review and meta-analysis","volume":"58","author":"Orgeta","year":"2017","journal-title":"J Alzheimers Dis."},{"key":"B411","first-page":"37","article-title":"Serotonin norepinephrine reuptake inhibitors: a pharmacological comparison","volume":"11","author":"Sansone","year":"2014","journal-title":"Innov Clin Neurosci."},{"key":"B412","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.14336\/AD.2021.0526","article-title":"Depression and dementia in older adults: a neuropsychological review","volume":"12","author":"Tetsuka","year":"2021","journal-title":"Aging Dis."},{"key":"B413","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/j.1532-5415.1994.tb04969.x","article-title":"Validating the GDS depression screen in the nursing home","volume":"42","author":"McGivney","year":"1994","journal-title":"J Am Geriatr Soc."},{"key":"B414","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1176\/appi.ajgp.10.2.125","article-title":"Provisional diagnostic criteria for depression of Alzheimer disease","volume":"10","author":"Olin","year":"2002","journal-title":"Am J Geriatr Psychiatry."},{"key":"B415","doi-asserted-by":"publisher","first-page":"Cd009125","DOI":"10.1002\/14651858.CD009125.pub2","article-title":"Psychological treatments for depression and anxiety in dementia and mild cognitive impairment","volume":"2014","author":"Orgeta","year":"2014","journal-title":"Cochr Database Syst Rev."},{"key":"B416","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.2174\/1381612825666191011102444","article-title":"NMDA receptor antagonists: repositioning of memantine as a multitargeting agent for Alzheimer's therapy","volume":"25","author":"Kabir","year":"2019","journal-title":"Curr Pharm Des."},{"key":"B417","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/j.1476-5381.2012.02057.x","article-title":"Alzheimer's disease, \u03b2-amyloid, glutamate, NMDA receptors and memantine\u2013searching for the connections","volume":"167","author":"Danysz","year":"2012","journal-title":"Br J Pharmacol."},{"key":"B418","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3233\/JAD-181106","article-title":"Treatment of Alzheimer's disease: trazodone, sleep, serotonin, norepinephrine, and future directions","volume":"67","author":"Ashford","year":"2019","journal-title":"J Alzheimers Dis."},{"key":"B419","doi-asserted-by":"publisher","first-page":"214","DOI":"10.4414\/pc-f.2013.00551","article-title":"Benzodiazepine pharmacology and central nervous system-mediated effects","volume":"13","author":"Griffin CE","year":"2013","journal-title":"Ochsner J."},{"key":"B420","doi-asserted-by":"publisher","first-page":"E517","DOI":"10.1503\/cmaj.170193","article-title":"The harms of benzodiazepines for patients with dementia","volume":"189","author":"Rochon","year":"2017","journal-title":"CMAJ."},{"key":"B421","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3389\/fnagi.2019.00344","article-title":"Benzodiazepines and related drugs as a risk factor in Alzheimer's disease dementia","volume":"11","author":"Ettcheto","year":"2019","journal-title":"Front Aging Neurosci."},{"key":"B422","doi-asserted-by":"publisher","first-page":"e12309","DOI":"10.1002\/trc2.12309","article-title":"Benzodiazepine use and the risk of dementia","volume":"8","author":"Joyce","year":"2022","journal-title":"Alzheimers Dement."},{"key":"B423","first-page":"469","article-title":"Buspirone for anxiety and agitation in dementia","volume":"28","author":"Cooper","year":"2003","journal-title":"J Psychiatry Neurosci."},{"key":"B424","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1586\/14737175.3.1.19","article-title":"Buspirone in Alzheimer's disease","volume":"3","author":"Desai","year":"2003","journal-title":"Expert Rev Neurother."},{"key":"B425","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1017\/S1041610216002441","article-title":"Buspirone for the treatment of dementia with behavioral disturbance","volume":"29","author":"Santa Cruz","year":"2017","journal-title":"Int Psychogeriatr."},{"key":"B426","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006815.pub2","article-title":"Hydroxyzine for generalised anxiety disorder","author":"Guaiana","year":"2010","journal-title":"Cochr Database Syst Rev"},{"key":"B427","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2165\/11633250-000000000-00000","article-title":"A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs","volume":"29","author":"Tannenbaum","year":"2012","journal-title":"Drugs Aging."},{"key":"B428","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2165\/00002512-200825030-00002","article-title":"Use of gabapentin in the treatment of behavioural and psychological symptoms of dementia","volume":"25","author":"Kim","year":"2008","journal-title":"Drugs Aging."},{"key":"B429","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/cpdd.446","article-title":"Gabapentin and pregabalin for the treatment of anxiety disorders","volume":"7","author":"Greenblatt","year":"2018","journal-title":"Clin Pharmacol Drug Dev."},{"key":"B430","doi-asserted-by":"publisher","first-page":"6045017","DOI":"10.1155\/2017\/6045017","article-title":"Treatment of generalized anxiety disorder with gabapentin","volume":"2017","author":"Markota","year":"2017","journal-title":"Case Rep Psychiatry."},{"key":"B431","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer's disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature."},{"key":"B432","doi-asserted-by":"publisher","first-page":"797","DOI":"10.2147\/CIA.S325026","article-title":"Role of aducanumab in the treatment of Alzheimer's disease: challenges and opportunities","volume":"17","author":"Vaz","year":"2022","journal-title":"Clin Interv Aging."},{"key":"B433","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s40265-021-01569-z","article-title":"Aducanumab: first approval","volume":"81","author":"Dhillon","year":"2021","journal-title":"Drugs."},{"key":"B434","volume-title":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury","year":"2012"},{"key":"B435","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med."},{"key":"B436","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.3233\/JAD-230164","article-title":"Effect of lecanemab in early Alzheimer's disease: mechanistic interpretation in the amyloid cascade hypothesis 20 perspective","volume":"93","author":"Volloch","year":"2023","journal-title":"J Alzheimers Dis."},{"key":"B437","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1212\/WNL.0000000000207505","article-title":"Lecanemab: looking before we leap","volume":"101","author":"Burke","year":"2023","journal-title":"Neurology."},{"key":"B438","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA."},{"key":"B439","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/healthcare11010032","article-title":"Donanemab for Alzheimer's disease: a systematic review of clinical trials","volume":"11","author":"Rashad","year":"2022","journal-title":"Healthcare"},{"key":"B440","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s40120-022-00416-x","article-title":"Non-drug therapies for Alzheimer's disease: a review","volume":"12","author":"Li","year":"2023","journal-title":"Neurol Therapy."},{"key":"B441","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1192\/bjp.183.3.248","article-title":"Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomised controlled trial","volume":"183","author":"Spector","year":"2003","journal-title":"Br J Psychiatry."},{"key":"B442","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1080\/23279095.2019.1710510","article-title":"The effect of cognitive stimulation on the progression of cognitive impairment in subjects with Alzheimer's disease","volume":"29","author":"L\u00f3pez","year":"2022","journal-title":"Appl Neuropsychol Adult."},{"key":"B443","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/psyg.12145","article-title":"Evaluation of the efficacy of animal-assisted therapy based on the reality orientation therapy protocol in Alzheimer's disease patients: a pilot study","volume":"16","author":"Menna","year":"2016","journal-title":"Psychogeriatrics."},{"key":"B444","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1177\/1533317514568004","article-title":"The effectiveness of reality orientation in the treatment of Alzheimer's disease","volume":"30","author":"Camargo","year":"2015","journal-title":"Am J Alzheimers Dis Other Dement."},{"key":"B445","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3390\/nursrep12040076","article-title":"Effect of music therapy as a non-pharmacological measure applied to Alzheimer's disease patients: a systematic review","volume":"12","author":"Garc\u00eda-Navarro","year":"2022","journal-title":"Nurs Rep."},{"key":"B446","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/nyas.14864","article-title":"The promise of music therapy for Alzheimer's disease: A review","volume":"1516","author":"Matziorinis","year":"2022","journal-title":"Ann N Y Acad Sci."},{"key":"B447","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1080\/09658210701734593","article-title":"Characterization of music-evoked autobiographical memories","volume":"15","author":"Janata","year":"2007","journal-title":"Memory."},{"key":"B448","doi-asserted-by":"publisher","first-page":"117350","DOI":"10.1016\/j.neuroimage.2020.117350","article-title":"A coordinate-based meta-analysis of music-evoked emotions","volume":"223","author":"Koelsch","year":"2020","journal-title":"Neuroimage."},{"key":"B449","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3233\/JAD-180183","article-title":"the effects of music therapy on cognition, psychiatric symptoms, and activities of daily living in patients with Alzheimer's disease","volume":"64","author":"Lyu","year":"2018","journal-title":"J Alzheimers Dis."},{"key":"B450","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.jagp.2015.07.007","article-title":"Drug and exercise treatment of Alzheimer disease and mild cognitive impairment: a systematic review and meta-analysis of effects on cognition in randomized controlled trials","volume":"23","author":"Str\u00f6hle","year":"2015","journal-title":"Am J Geriatr Psychiatry."},{"key":"B451","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.regg.2015.10.006","article-title":"Effectiveness of occupational therapy and other non-pharmacological therapies in cognitive impairment and Alzheimer's disease","volume":"51","author":"Matilla-Mora","year":"2016","journal-title":"Rev Esp Geriatr Gerontol."},{"key":"B452","doi-asserted-by":"publisher","first-page":"9","DOI":"10.21801\/ppcrj.2023.92.8","article-title":"Effect of occupational therapy on cognition in patients with mild Alzheimer's disease: a systematized literature review","author":"Ramin-Wright","year":"2023","journal-title":"Princip Pract Clin Res"},{"key":"B453","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/JGP.0b013e3181c37d13","article-title":"The cost-effectiveness of a nonpharmacologic intervention for individuals with dementia and family caregivers: the tailored activity program","volume":"18","author":"Gitlin","year":"2010","journal-title":"Am J Geriatr Psychiatry."},{"key":"B454","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/geront\/gnp087","article-title":"The Tailored Activity Program to reduce behavioral symptoms in individuals with dementia: feasibility, acceptability, and replication potential","volume":"49","author":"Gitlin","year":"2009","journal-title":"Gerontologist."},{"key":"B455","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1037\/0882-7974.22.2.361","article-title":"Positive aspects of caregiving as a moderator of treatment outcome over 12 months","volume":"22","author":"Hilgeman","year":"2007","journal-title":"Psychol Aging."},{"key":"B456","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.3390\/healthcare10091764","article-title":"Occupational therapy interventions for dementia caregivers: scoping review","volume":"10","author":"Mart\u00ednez-Campos","year":"2022","journal-title":"Healthcare"},{"key":"B457","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/07380577.2019.1608488","article-title":"Sensory-based interventions for adults with dementia and Alzheimer's disease: a scoping review","volume":"34","author":"Smith","year":"2020","journal-title":"Occup Therapy Health Care."},{"key":"B458","doi-asserted-by":"publisher","first-page":"1213223","DOI":"10.3389\/fnut.2023.1213223","article-title":"Diet and lifestyle impact the development and progression of Alzheimer's dementia","volume":"10","author":"Arora","year":"2023","journal-title":"Front Nutr."},{"key":"B459","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/diseases7010012","article-title":"Modulating effect of diet on Alzheimer's disease","volume":"7","author":"Fern\u00e1ndez-Sanz","year":"2019","journal-title":"Diseases"},{"key":"B460","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1096\/fj.14-264218","volume":"29","author":"Fiala","year":"2015","journal-title":"FASEB J."},{"key":"B461","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jnutbio.2016.03.002","article-title":"The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease","volume":"38","author":"Belkouch","year":"2016","journal-title":"J Nutr Biochem."},{"key":"B462","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.3945\/ajcn.117.162263","article-title":"A high-glycemic diet is associated with cerebral amyloid burden in cognitively normal older adults","volume":"106","author":"Taylor","year":"2017","journal-title":"Am J Clin Nutr."},{"key":"B463","doi-asserted-by":"publisher","first-page":"nzz003","DOI":"10.1093\/cdn\/nzz003","article-title":"An experimental ketogenic diet for Alzheimer disease was nutritionally dense and rich in vegetables and avocado","volume":"3","author":"Taylor","year":"2019","journal-title":"Curr Dev Nutr"},{"key":"B464","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/advances\/nmz104","article-title":"Utility of ketone supplementation to enhance physical performance: a systematic review","volume":"11","author":"Margolis","year":"2020","journal-title":"Adv Nutr."},{"key":"B465","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12974-023-02753-6","article-title":"Exercise suppresses neuroinflammation for alleviating Alzheimer's disease","volume":"20","author":"Wang","year":"2023","journal-title":"J Neuroinflamm."},{"key":"B466","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/mp.2012.162","article-title":"Multiple effects of physical activity on molecular and cognitive signs of brain aging: can exercise slow neurodegeneration and delay Alzheimer's disease?","volume":"18","author":"Brown","year":"2013","journal-title":"Mol Psychiatry."},{"key":"B467","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.gerinurse.2023.04.012","article-title":"Effects of physical activity interventions on executive function in older adults with dementia: A meta-analysis of randomized controlled trials","volume":"51","author":"Zeng","year":"2023","journal-title":"Geriatr Nurs."},{"key":"B468","doi-asserted-by":"publisher","first-page":"15700","DOI":"10.3390\/ijerph192315700","article-title":"The effect of aerobic exercise on cognitive function in people with Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials","volume":"19","author":"Zhang","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B469","doi-asserted-by":"publisher","first-page":"109420","DOI":"10.1016\/j.cellsig.2019.109420","article-title":"Alzheimer's disease pathogenesis: the role of disturbed sleep in attenuated brain plasticity and neurodegenerative processes","volume":"64","author":"Havekes","year":"2019","journal-title":"Cell Signal."},{"key":"B470","doi-asserted-by":"publisher","first-page":"101046","DOI":"10.1016\/j.arr.2020.101046","article-title":"Circadian and sleep dysfunction in Alzheimer's disease","volume":"60","author":"Uddin","year":"2020","journal-title":"Ageing Res Rev."},{"key":"B471","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1177\/1533317506295377","article-title":"Language-enriched exercise plus socialization slows cognitive decline in Alzheimer's disease","volume":"22","author":"Arkin","year":"2007","journal-title":"Am J Alzheimers Dis Other Dement."},{"key":"B472","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3390\/neurolint15010013","article-title":"Thwarting alzheimer's disease through healthy lifestyle habits: hope for the future","volume":"15","author":"Govindugari","year":"2023","journal-title":"Neurol Int."},{"key":"B473","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1002\/bab.2216","article-title":"Chronic stress and Alzheimer's disease","volume":"69","author":"Mohammadi","year":"2022","journal-title":"Biotechnol Appl Biochem."},{"key":"B474","unstructured":"The coping strategies, adjustment and well being of male inmates in the prison environment129\n PickenJ\n Int J Criminol.20122012"},{"key":"B475","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1464-0597.2009.00378.x","article-title":"The ways of coping checklist revision-Asian version (WCCL-ASIAN): a new factor structure with confirmatory factor analysis","volume":"59","author":"Sawang","year":"2011","journal-title":"Appl Psychol."},{"key":"B476","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12877-023-03785-6","article-title":"Development and validation of care stress management scale in family caregivers for people with Alzheimer: a sequential-exploratory mixed-method study","volume":"23","author":"Sharif Nia","year":"2023","journal-title":"BMC Geriatr."},{"key":"B477","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer's disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet."},{"key":"B478","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.trci.2019.05.008","article-title":"Alzheimer's disease drug development pipeline: 2019","volume":"5","author":"Cummings","year":"2019","journal-title":"Alzheimers Dement."},{"key":"B479","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1017\/S1041610216001460","article-title":"Does physical exercise improve ADL capacities in people over 65 years with moderate or severe dementia hospitalized in an acute psychiatric setting? A multisite randomized clinical trial","volume":"29","author":"B\u00fcrge","year":"2017","journal-title":"Int Psychogeriatr."},{"key":"B480","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1177\/0269215514554240","article-title":"The effects of ear acupressure, massage therapy and no therapy on symptoms of dementia: a randomized controlled trial","volume":"29","author":"Rodr\u00edguez-Mansilla","year":"2015","journal-title":"Clin Rehabil."},{"key":"B481","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3233\/JAD-130893","article-title":"Efficacy of musical interventions in dementia: evidence from a randomized controlled trial","volume":"38","author":"Narme","year":"2014","journal-title":"J Alzheimers Dis."},{"key":"B482","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/jgs.13880","article-title":"Effects of a high-intensity functional exercise program on dependence in activities of daily living and balance in older adults with dementia","volume":"64","author":"Toots","year":"2016","journal-title":"J Am Geriatr Soc."},{"key":"B483","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1017\/S1041610209008886","article-title":"Bright light therapy for agitation in dementia: a randomized controlled trial","volume":"21","author":"Burns","year":"2009","journal-title":"Int Psychogeriatr."},{"key":"B484","doi-asserted-by":"publisher","first-page":"Cd013069","DOI":"10.1002\/14651858.CD013069.pub2","article-title":"Cognitive training for people with mild to moderate dementia","volume":"3","author":"Bahar-Fuchs","year":"2019","journal-title":"Cochr Database Syst Rev."},{"key":"B485","doi-asserted-by":"publisher","first-page":"325","DOI":"10.30773\/pi.2019.02.11.2","article-title":"A systematic review and meta-analysis of nonpharmacological interventions for moderate to severe dementia","volume":"16","author":"Na","year":"2019","journal-title":"Psychiatry Investig."},{"key":"B486","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","article-title":"Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria","volume":"12","author":"Dubois","year":"2016","journal-title":"Alzheimers Dement."},{"key":"B487","doi-asserted-by":"publisher","first-page":"1179573520907397","DOI":"10.1177\/1179573520907397","article-title":"Current and future treatments in Alzheimer disease: an update","volume":"12","author":"Yiannopoulou","year":"2020","journal-title":"J Cent Nerv Syst Dis."},{"key":"B488","doi-asserted-by":"publisher","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of aducanumab in early Alzheimer's disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J Prev Alzheimers Dis."},{"key":"B489","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1312889","article-title":"Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease","volume":"370","author":"Doody","year":"2014","journal-title":"N Engl J Med."},{"key":"B490","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/s41591-021-01369-8","article-title":"A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease","volume":"27","author":"Salloway","year":"2021","journal-title":"Nat Med."},{"key":"B491","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1056\/NEJMoa2305032","article-title":"Trial of solanezumab in preclinical Alzheimer's disease","volume":"389","author":"Sperling","year":"2023","journal-title":"N Engl J Med."},{"key":"B492","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease","volume":"370","author":"Salloway","year":"2014","journal-title":"N Engl J Med."},{"key":"B493","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1001\/jamaneurol.2022.2909","article-title":"Evaluating the safety and efficacy of crenezumab vs placebo in adults with early Alzheimer disease: two phase 3 randomized placebo-controlled trials","volume":"79","author":"Ostrowitzki","year":"2022","journal-title":"JAMA Neurol."},{"key":"B494","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000203868","article-title":"GRADUATE I AND II: findings of two phase iii randomized placebo-controlled studies assessing the efficacy and safety of subcutaneous gantenerumab in early Alzheimer's disease (AD) (S26.010","author":"Smith","year":"2023","journal-title":"Neurology"},{"key":"B495","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/jamaneurol.2022.1375","article-title":"Safety and efficacy of semorinemab in individuals with prodromal to mild Alzheimer disease: a randomized clinical trial","volume":"79","author":"Teng","year":"2022","journal-title":"JAMA Neurol."},{"key":"B496","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1038\/s43587-023-00523-w","article-title":"TANGO: a placebo-controlled randomized phase 2 study of efficacy and safety of the anti-tau monoclonal antibody gosuranemab in early Alzheimer's disease","volume":"3","author":"Shulman","year":"2023","journal-title":"Nat Aging."},{"key":"B497","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1093\/brain\/awad024","article-title":"Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study","volume":"146","author":"Florian","year":"2023","journal-title":"Brain."},{"key":"B498","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1001\/jamaneurol.2023.3861","article-title":"Exploratory tau biomarker results from a multiple ascending-dose study of BIIB080 in Alzheimer disease: a randomized clinical trial","volume":"80","author":"Edwards","year":"2023","journal-title":"JAMA Neurol."},{"key":"B499","doi-asserted-by":"publisher","first-page":"2261509","DOI":"10.1080\/19420862.2023.2261509","article-title":"Delivery of the Brainshuttle\u2122 amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans","volume":"15","author":"Grimm","year":"2023","journal-title":"MAbs."},{"key":"B500","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.trci.2019.01.001","article-title":"Plasma exchange for Alzheimer's disease management by albumin replacement (AMBAR) trial: study design and progress","volume":"5","author":"Boada","year":"2019","journal-title":"Alzheimers Dement."},{"key":"B501","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1212\/WNL.0000000000003904","article-title":"A phase 3 trial of IV immunoglobulin for Alzheimer disease","volume":"88","author":"Relkin","year":"2017","journal-title":"Neurology."},{"key":"B502","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1089\/hum.2016.017","article-title":"Gene therapy strategies for Alzheimer's disease: an overview","volume":"27","author":"Alves","year":"2016","journal-title":"Hum Gene Ther."},{"key":"B503","doi-asserted-by":"publisher","first-page":"246","DOI":"10.2174\/1566523221666210120091146","article-title":"Efficacy of gene therapy to restore cognition in Alzheimer's disease: a systematic review","volume":"21","author":"Tedeschi","year":"2021","journal-title":"Curr Gene Ther."},{"key":"B504","doi-asserted-by":"publisher","first-page":"8723","DOI":"10.1002\/jcb.27202","article-title":"Stem cell- and gene-based therapies as potential candidates in Alzheimer's therapy","volume":"119","author":"Hosseini","year":"2018","journal-title":"J Cell Biochem."},{"key":"B505","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1007\/s12035-018-1167-9","article-title":"Neuronal and glial differentiation of human neural stem cells is regulated by amyloid precursor protein (APP) levels","volume":"56","author":"Coronel","year":"2019","journal-title":"Mol Neurobiol."},{"key":"B506","doi-asserted-by":"publisher","first-page":"14776","DOI":"10.1038\/s41598-018-33017-6","article-title":"Human neural stem cell transplantation improves cognition in a murine model of Alzheimer's disease","volume":"8","author":"McGinley","year":"2018","journal-title":"Sci Rep."},{"key":"B507","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13195-021-00791-x","article-title":"Human neural stem cell-derived extracellular vesicles mitigate hallmarks of Alzheimer's disease","volume":"13","author":"Apodaca","year":"2021","journal-title":"Alzheimers Res Ther."},{"key":"B508","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.bbrc.2020.02.074","article-title":"Disrupted blood-brain barrier in 5\u00d7 FAD mouse model of Alzheimer's disease can be mimicked and repaired in vitro with neural stem cell-derived exosomes","volume":"525","author":"Liu","year":"2020","journal-title":"Biochem Biophys Res Commun."},{"key":"B509","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.3390\/ijms21113958","article-title":"Human neural stem cells encoding ChAT gene restore cognitive function via acetylcholine synthesis, A\u03b2 elimination, and neuroregeneration in APPswe\/PS1dE9 mice","volume":"21","author":"Park","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B510","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.3892\/mmr.2020.10918","article-title":"Neural stem cell transplantation improves learning and memory by protecting cholinergic neurons and restoring synaptic impairment in an amyloid precursor protein\/presenilin 1 transgenic mouse model of Alzheimer's disease","volume":"21","author":"Zhu","year":"2020","journal-title":"Mol Med Rep."},{"key":"B511","doi-asserted-by":"publisher","first-page":"650103","DOI":"10.3389\/fnagi.2021.650103","article-title":"Intranasal transplantation of human neural stem cells ameliorates Alzheimer's disease-like pathology in a mouse model","volume":"13","author":"Lu","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"B512","doi-asserted-by":"publisher","first-page":"314324","DOI":"10.4103\/1673-5374.314324","article-title":"Neural stem cell transplantation alleviates functional cognitive deficits in a mouse model of tauopathy","volume":"17","author":"Zhang","year":"2022","journal-title":"Neur Regener Res"},{"key":"B513","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13195-021-00897-2","article-title":"Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: a phase I clinical trial","volume":"13","author":"Kim","year":"2021","journal-title":"Alzheimers Res Therapy."},{"key":"B514","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-200219","article-title":"Mesenchymal stem cell therapy and Alzheimer's disease: current status and future perspectives","volume":"77","author":"Kim","year":"2020","journal-title":"J Alzheimers Dis."},{"key":"B515","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3233\/JAD-200026","article-title":"Feasibility and efficacy of intra-arterial administration of embryonic stem cell derived-mesenchymal stem cells in animal model of Alzheimer's disease","volume":"76","author":"Kim","year":"2020","journal-title":"J Alzheimers Dis."},{"key":"B516","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3390\/biomedicines11010120","article-title":"stem cell therapy for Alzheimer;s disease: a scoping review for 2017\u20132022","volume":"11","author":"Duan","year":"2023","journal-title":"Biomedicines"},{"key":"B517","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13024-016-0106-3","article-title":"Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy","volume":"11","author":"Yang","year":"2016","journal-title":"Mol Neurodegener."},{"key":"B518","doi-asserted-by":"publisher","DOI":"10.2174\/1567205020666230206124155","article-title":"Digital intervention for the management of Alzheimer's disease","author":"Manchanda","year":"2023","journal-title":"Curr Alzheimer Res."},{"key":"B519","doi-asserted-by":"publisher","first-page":"e0177044","DOI":"10.1371\/journal.pone.0177044","article-title":"Comorbidity and progression of late onset Alzheimer's disease: a systematic review","volume":"12","author":"Haaksma","year":"2017","journal-title":"PLoS ONE."},{"key":"B520","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/1097-0029(20000815)50:4<287::AID-JEMT7>3.0.CO;2-L","article-title":"Link between heart disease, cholesterol, and Alzheimer's disease: a review","volume":"50","author":"Sparks","year":"2000","journal-title":"Microsc Res Tech"},{"key":"B521","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.nrleng.2016.02.009","article-title":"Prevalence and incidence of Alzheimer's disease in Europe: a meta-analysis","volume":"32","author":"Niu","year":"2017","journal-title":"Neurolog"},{"key":"B522","doi-asserted-by":"publisher","first-page":"M173","DOI":"10.1093\/gerona\/57.3.M173","article-title":"Prevalence and impact of medical comorbidity in Alzheimer's disease","volume":"57","author":"Doraiswamy","year":"2002","journal-title":"J Gerontol Ser A."},{"key":"B523","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1177\/0891988706286505","article-title":"Vascular disease and risk factors, rate of progression, and survival in Alzheimer's disease","volume":"19","author":"Bhargava","year":"2006","journal-title":"J Geriatr Psychiatry Neurol."},{"key":"B524","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1385\/MN:31:1-3:185","article-title":"Is hypercholesterolemia a risk factor for Alzheimer's disease?","volume":"31","author":"Wood","year":"2005","journal-title":"Mol Neurobiol."},{"key":"B525","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.clinthera.2021.05.006","article-title":"Modifiable risk factors in Alzheimer disease and related dementias: a review","volume":"43","author":"Litke","year":"2021","journal-title":"Clin Ther."},{"key":"B526","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.diabres.2016.10.024","article-title":"An updated meta-analysis of cohort studies: diabetes and risk of Alzheimer's disease","volume":"124","author":"Zhang","year":"2017","journal-title":"Diabetes Res Clin Pract."},{"key":"B527","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2174\/156720507780362047","article-title":"Body mass index in midlife and risk of Alzheimer disease and vascular dementia","volume":"4","author":"Whitmer","year":"2007","journal-title":"Curr Alzheimer Res."},{"key":"B528","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s11065-012-9193-2","article-title":"Family history and APOE-4 genetic risk in Alzheimer's disease","volume":"22","author":"Donix","year":"2012","journal-title":"Neuropsychol Rev."},{"key":"B529","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.jalz.2014.06.015","article-title":"APOE","volume":"10","author":"Michaelson","year":"2014","journal-title":"Alzheimers Dement."},{"key":"B530","author":"Werner","year":"2014","journal-title":"Stigma and Alzheimer's Disease: A Systematic Review of Evidence, Theory, and Methods"},{"key":"B531","doi-asserted-by":"publisher","first-page":"841941","DOI":"10.4061\/2010\/841941","article-title":"To know or not to know: ethical issues related to early diagnosis of Alzheimer's disease","volume":"2010","author":"Mattsson","year":"2010","journal-title":"Int J Alzheimers Dis"},{"key":"B532","doi-asserted-by":"publisher","first-page":"6","DOI":"10.2174\/1874434601307010006","article-title":"Informal caregivers of people with dementia: problems, needs and support in the initial stage and in subsequent stages of dementia: a questionnaire survey","volume":"7","author":"Zwaanswijk","year":"2013","journal-title":"Open Nurs J."},{"key":"B533","first-page":"189","volume-title":"Executive Function and Activities of Daily Living in Alzheimer's Disease: A Correlational Meta-analysis","author":"Martyr","year":"2012"},{"key":"B534","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1080\/13607863.2011.651437","article-title":"The relationship between self-efficacy and positive aspects of caregiving in Alzheimer's disease caregivers","volume":"16","author":"Semiatin","year":"2012","journal-title":"Aging Ment Health."},{"key":"B535","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/geront\/33.6.747","article-title":"Coping with specific stressors in Alzheimer's disease caregiving","volume":"33","author":"Williamson","year":"1993","journal-title":"Gerontologist."},{"key":"B536","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41746-021-00506-4","article-title":"Scoping review: the empowerment of Alzheimer's Disease caregivers with mHealth applications","volume":"4","author":"Kim","year":"2021","journal-title":"NPJ digital medicine."},{"key":"B537","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1145\/3359232","article-title":"Caring for Alzheimer's disease caregivers: a qualitative study investigating opportunities for Exergame innovation","volume":"3","author":"Stowell","year":"2019","journal-title":"Proc ACM Hum Comp Interact"},{"key":"B538","doi-asserted-by":"publisher","first-page":"8838","DOI":"10.3390\/ijerph18168838","article-title":"Alzheimer's disease caregiver characteristics and their relationship with anticipatory grief","volume":"18","author":"P\u00e9rez-Gonz\u00e1lez","year":"2021","journal-title":"Int J Environ Res Public Health."},{"key":"B539","doi-asserted-by":"crossref","DOI":"10.1093\/med-psych\/9780190855949.001.0001","volume-title":"The REACH OUT Caregiver Support Program: A Skills Training Program for Caregivers of Persons with Dementia, Clinician Guide.","author":"Burgio","year":"2021"},{"key":"B540","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1080\/13607863.2020.1850638","article-title":"Translating the REACH OUT dementia caregiver intervention into a primary care setting: a pilot study","volume":"25","author":"Sikora Kessler","year":"2021","journal-title":"Aging Ment Health."},{"key":"B541","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12875-021-01528-3","article-title":"Needs of patients with dementia and their caregivers in primary care: lessons learned from the Alzheimer plan of Quebec","volume":"22","author":"Khanassov","year":"2021","journal-title":"BMC Fam Pract."},{"key":"B542","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/alz.12188","article-title":"Toward a theory-based specification of non-pharmacological treatments in aging and dementia: focused reviews and methodological recommendations","volume":"17","author":"Sikkes","year":"2021","journal-title":"Alzheimers Dement."},{"key":"B543","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1080\/13607863.2019.1590310","article-title":"Enhancing communication between dementia care staff and their residents: an arts-inspired intervention","volume":"24","author":"Windle","year":"2020","journal-title":"Aging Ment Health."},{"key":"B544","doi-asserted-by":"publisher","first-page":"e13417","DOI":"10.2196\/13417","article-title":"Development and usability of ADappt: web-based tool to support clinicians, patients, and caregivers in the diagnosis of mild cognitive impairment and Alzheimer disease","volume":"3","author":"van Maurik","year":"2019","journal-title":"JMIR Form Res."},{"key":"B545","doi-asserted-by":"publisher","first-page":"640669","DOI":"10.3389\/fcomp.2021.640669","article-title":"Alzheimer's dementia recognition from spontaneous speech using disfluency and interactional features","volume":"3","author":"Nasreen","year":"2021","journal-title":"Front Comp Sci."},{"key":"B546","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3390\/healthcare9081036","article-title":"Conversational system as assistant tool in reminiscence therapy for people with early-stage of alzheimer's","volume":"9","author":"Morales-de-Jes\u00fas","year":"2021","journal-title":"Healthcare."},{"key":"B547","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/jmwh.13150","article-title":"The ethical imperative of self-care: a call to action","volume":"65","author":"Wright","year":"2020","journal-title":"J Midwif Womens Health."},{"key":"B548","doi-asserted-by":"publisher","first-page":"603a","DOI":"10.1037\/0735-7028.38.6.603","article-title":"In pursuit of wellness: the self-care imperative","volume":"38","author":"Barnett","year":"2007","journal-title":"Prof Psychol."},{"key":"B549","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/01939450222045716","article-title":"Health-promoting self-care in family caregivers","volume":"24","author":"Acton","year":"2002","journal-title":"West J Nurs Res."},{"key":"B550","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1177\/089826439700900306","article-title":"Predictors of decreased self-care among spouse caregivers of older adults with dementing illnesses","volume":"9","author":"Gallant","year":"1997","journal-title":"J Aging Health."},{"key":"B551","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.archger.2010.04.011","article-title":"Association between the caregiver's burden and physical activity in community-dwelling caregivers of dementia patients","volume":"52","author":"Hirano","year":"2011","journal-title":"Arch Gerontol Geriatr."},{"key":"B552","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1093\/geront\/gnw078","article-title":"Hearing their voice: a systematic review of dementia family caregivers' needs","volume":"56","author":"McCabe","year":"2016","journal-title":"Gerontologist."},{"key":"B553","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1017\/S1368980099000567","article-title":"The influence of physical activity on mental well-being","volume":"2","author":"Fox","year":"1999","journal-title":"Public Health Nutr"},{"key":"B554","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.jand.2012.06.015","article-title":"Position of the Academy of Nutrition and Dietetics: food and nutrition for older adults: promoting health and wellness","volume":"112","author":"Bernstein","year":"2012","journal-title":"J Acad Nutr Diet."},{"key":"B555","author":"Ryan","year":"2012","journal-title":"A Mindful Nation: How a Simple Practice Can Help Us Reduce Stress, Improve Performance, and Recapture the American Spirit."},{"key":"B556","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1037\/0022-3514.84.4.822","article-title":"The benefits of being present: mindfulness and its role in psychological well-being","volume":"84","author":"Brown","year":"2003","journal-title":"J Pers Soc Psychol."},{"key":"B557","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/cp.12084","article-title":"A preliminary evaluation of a single session behavioural activation intervention to improve well-being and prevent depression in carers","volume":"20","author":"Read","year":"2016","journal-title":"Clin Psychol."},{"key":"B558","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1177\/1533317515576389","article-title":"Meaningful activity for persons with dementia: family caregiver perspectives","volume":"30","author":"Roland","year":"2015","journal-title":"Am J Alzheimers Dis Other Dement."},{"key":"B559","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/j.1365-2648.2010.05261.x","article-title":"The legitimacy of rest: conditions for the relief of burden in advanced dementia care-giving","volume":"66","author":"de","year":"2010","journal-title":"J Adv Nurs"},{"key":"B560","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1748-3743.2012.00340.x","article-title":"Experiences of long-term home care as an informal caregiver to a spouse: gendered meanings in everyday life for female carers","volume":"8","author":"Eriksson","year":"2013","journal-title":"Int J Older People Nurs."},{"key":"B561","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/0898010113509724","article-title":"Strategies for sustaining self used by family caregivers for older adults with dementia","volume":"32","author":"Bull","year":"2014","journal-title":"J Holist Nurs."},{"key":"B562","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1177\/1049732308327158","article-title":"Self-care behaviors of spouses caring for significant others with Alzheimer's disease: the emergence of self-care worthiness as a salient condition","volume":"18","author":"Furlong","year":"2008","journal-title":"Qual Health Res."},{"key":"B563","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12877-016-0268-4","article-title":"Self-management by family caregivers to manage changes in the behavior and mood of their relative with dementia: an online focus group study","volume":"16","author":"Verkaik","year":"2016","journal-title":"BMC Geriatr."},{"key":"B564","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1177\/1533317516628518","article-title":"Experiences and learning needs of African American family dementia caregivers","volume":"31","author":"Samson","year":"2016","journal-title":"Am J Alzheimers Dis Other Dement."},{"key":"B565","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3928\/19404921-20160928-01","article-title":"How do we promote health?","volume":"9","author":"Epps","year":"2016","journal-title":"Res Gerontol Nurs."},{"key":"B566","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jalz.2017.12.006","article-title":"The cost of Alzheimer's disease in China and re-estimation of costs worldwide","volume":"14","author":"Jia","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B567","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1515\/fhep-2014-0013","article-title":"The value of delaying Alzheimer's disease onset","volume":"18","author":"Zissimopoulos","year":"2014","journal-title":"Forum Health Econ Policy."},{"key":"B568","doi-asserted-by":"publisher","first-page":"1667195","DOI":"10.1080\/20016689.2019.1667195","article-title":"Economic burden for Alzheimer's disease in China from 2010 to 2050: a modelling study","volume":"7","author":"Clay","year":"2019","journal-title":"J Mark Access Health Policy."},{"key":"B569","doi-asserted-by":"publisher","first-page":"e0210958","DOI":"10.1371\/journal.pone.0210958","article-title":"Predictions of Alzheimer's disease treatment and care costs in European countries","volume":"14","author":"Cimler","year":"2019","journal-title":"PLoS ONE."},{"key":"B570","unstructured":"Alzheimer'sAssociation\n Power of Attorney| Legal Documents| Financial and Legal Planning for Caregivers2021"},{"key":"B571","unstructured":"Alzheimer'sAssociation\n Guardianship\/Conservatorship | legal Documents| Financial and Legal Planning for Caregivers"},{"key":"B572","unstructured":"Traditional Medicare vs Medicare Advantage (and How Direct Contracting is the Next Step)2021"},{"key":"B573","unstructured":"Alzheimer'sAssociation\n Medicare| Financial and Legal Planning for Caregivers.2023"},{"key":"B574","unstructured":""},{"key":"B575","author":"Federal","year":"2023","journal-title":"Medicare and Medicaid Programs; CY 2024 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; Medicare Advantage; Medicare and Medicaid Provider and Supplier Enrollment Policies; and Basic Health Program"},{"key":"B576","doi-asserted-by":"publisher","first-page":"100","DOI":"10.36469\/jheor.2023.89151","article-title":"Value-based reimbursement as a mechanism to achieve social and financial impact in the healthcare system","volume":"10","author":"de Silva Etges","year":"2023","journal-title":"J Health Econ Outcomes Res."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1474043\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T23:19:18Z","timestamp":1734304758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1474043\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,16]]},"references-count":576,"alternative-id":["10.3389\/fmed.2024.1474043"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1474043","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,16]]},"article-number":"1474043"}}